1
|
Liu H, Zhang Y, Zhang Y, Huang Y, Yang Y, Zhao Y, Chen S, Deng J, Li W, Han B. Periodontal Ligament Cell Apoptosis Activates Lepr+ Osteoprogenitors in Orthodontics. J Dent Res 2024:220345241262706. [PMID: 39104161 DOI: 10.1177/00220345241262706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/07/2024] Open
Abstract
Alveolar bone (AB) remodeling, including formation and absorption, is the foundation of orthodontic tooth movement (OTM). However, the sources and mechanisms underlying new bone formation remain unclear. Therefore, we aimed to understand the potential mechanism of bone formation during OTM, focusing on the leptin receptor+ (Lepr+) osteogenitors and periodontal ligament cells (PDLCs). We demonstrated that Lepr+ cells activated by force-induced PDLC apoptosis served as distinct osteoprogenitors during orthodontic bone regeneration. We investigated bone formation both in vivo and in vitro. Single-cell RNA sequencing analysis and lineage tracing demonstrated that Lepr represents a subcluster of stem cells that are activated and differentiate into osteoblasts during OTM. Targeted ablation of Lepr+ cells in a mouse model disrupted orthodontic force-guided bone regeneration. Furthermore, apoptosis and sequential fluorescent labeling assays revealed that the apoptosis of PDLCs preceded new bone deposition. We found that PDL stem cell-derived apoptotic vesicles activated Lepr+ cells in vitro. Following apoptosis inhibition, orthodontic force-activated osteoprogenitors and osteogenesis were significantly downregulated. Notably, we found that bone formation occurred on the compression side during OTM; this has been first reported here. To conclude, we found a potential mechanism of bone formation during OTM that may provide new insights into AB regeneration.
Collapse
|
2
|
Deng J, Zhao Z, Yeo XY, Yang C, Yang J, Ferhan AR, Jin B, Oh C, Jung S, Suresh S, Cho NJ. Plant-Based Shape Memory Cryogel for Hemorrhage Control. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2024:e2311684. [PMID: 39011812 DOI: 10.1002/adma.202311684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/05/2023] [Revised: 06/24/2024] [Indexed: 07/17/2024]
Abstract
The escalating global demand for sustainable manufacturing, motivated by concerns over energy conservation and carbon footprints, encounters challenges due to insufficient renewable materials and arduous fabrication procedures to fulfill specific requirements in medical and healthcare systems. Here, biosafe pollen cryogel is engineered as effective hemostats without additional harmful crosslinkers to treat deep noncompressible wounds. A straightforward and low-energy approach is involved in forming stable macroporous cryogel, benefiting from the unique micro-hierarchical structures and chemical components of non-allergenic plant pollen. It is demonstrated that the pollen cryogel exhibits rapid water/blood-triggered shape-memory properties within 2 s. Owing to their inherent nano/micro hierarchical structure and abundant chemical functional groups on the pollen surface, the pollen cryogel shows effective hemostatic performance in a mouse liver penetration model, which is easily removed after usage. Overall, the self-crosslinking pollen cryogel in this work pioneers a framework of potential clinical applications for the first-hand treatment on deep noncompressible wounds.
Collapse
|
3
|
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adeva B, Adinolfi M, Adlarson P, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Alfonso Albero A, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreola P, Andreotti M, Andreou D, Anelli AA, Ao D, Archilli F, Argenton M, Arguedas Cuendis S, Artamonov A, Artuso M, Aslanides E, Atzeni M, Audurier B, Bacher D, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Bailly-Reyre A, Baladron Rodriguez P, Balagura V, Baldini W, Baptista de Souza Leite J, Barbetti M, Barbosa IR, Barlow RJ, Barsuk S, Barter W, Bartolini M, Baryshnikov F, Basels JM, Bassi G, Batsukh B, Battig A, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Beiter A, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Bernstein HC, Bertella C, Bertolin A, Betancourt C, Betti F, Bex J, Bezshyiko I, Bhom J, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blago MP, Blake T, Blanc F, Blank JE, Blusk S, Bobulska D, Bocharnikov V, Boelhauve JA, Boente Garcia O, Boettcher T, Bohare A, Boldyrev A, Bolognani CS, Bolzonella R, Bondar N, Borgato F, Borghi S, Borsato M, Borsuk JT, Bouchiba SA, Bowcock TJV, Boyer A, Bozzi C, Bradley MJ, Braun S, Brea Rodriguez A, Breer N, Brodzicka J, Brossa Gonzalo A, Brown J, Brundu D, Buonaura A, Buonincontri L, Burke AT, Burr C, Bursche A, Butkevich A, Butter JS, Buytaert J, Byczynski W, Cadeddu S, Cai H, Calabrese R, Calefice L, Cali S, Calvi M, Calvo Gomez M, Cambon Bouzas J, Campana P, Campora Perez DH, Campoverde Quezada AF, Capelli S, Capriotti L, Caravaca-Mora RC, Carbone A, Carcedo Salgado L, Cardinale R, Cardini A, Carniti P, Carus L, Casais Vidal A, Caspary R, Casse G, Castro Godinez J, Cattaneo M, Cavallero G, Cavallini V, Celani S, Cerasoli J, Cervenkov D, Cesare S, Chadwick AJ, Chahrour I, Charles M, Charpentier P, Chavez Barajas CA, Chefdeville M, Chen C, Chen S, Chernov A, Chernyshenko S, Chobanova V, Cholak S, Chrzaszcz M, Chubykin A, Chulikov V, Ciambrone P, Cicala MF, Cid Vidal X, Ciezarek G, Cifra P, Clarke PEL, Clemencic M, Cliff HV, Closier J, Cobbledick JL, Cocha Toapaxi C, Coco V, Cogan J, Cogneras E, Cojocariu L, Collins P, Colombo T, Comerma-Montells A, Congedo L, Contu A, Cooke N, Corredoira I, Correia A, Corti G, Cottee Meldrum JJ, Couturier B, Craik DC, Cruz Torres M, Currie R, Da Silva CL, Dadabaev S, Dai L, Dai X, Dall'Occo E, Dalseno J, D'Ambrosio C, Daniel J, Danilina A, d'Argent P, Davidson A, Davies JE, Davis A, De Aguiar Francisco O, De Angelis C, de Boer J, De Bruyn K, De Capua S, De Cian M, De Freitas Carneiro Da Graca U, De Lucia E, De Miranda JM, De Paula L, De Serio M, De Simone D, De Simone P, De Vellis F, de Vries JA, Debernardis F, Decamp D, Dedu V, Del Buono L, Delaney B, Dembinski HP, Deng J, Denysenko V, Deschamps O, Dettori F, Dey B, Di Nezza P, Diachkov I, Didenko S, Ding S, Dobishuk V, Docheva AD, Dolmatov A, Dong C, Donohoe AM, Dordei F, Dos Reis AC, Douglas L, Downes AG, Duan W, Duda P, Dudek MW, Dufour L, Duk V, Durante P, Duras MM, Durham JM, Dutta D, Dziurda A, Dzyuba A, Easo S, Eckstein E, Egede U, Egorychev A, Egorychev V, Eirea Orro C, Eisenhardt S, Ejopu E, Ek-In S, Eklund L, Elashri M, Ellbracht J, Ely S, Ene A, Epple E, Escher S, Eschle J, Esen S, Evans T, Fabiano F, Falcao LN, Fan Y, Fang B, Fantini L, Faria M, Farmer K, Fazzini D, Felkowski L, Feng M, Feo M, Fernandez Gomez M, Fernez AD, Ferrari F, Ferreira Rodrigues F, Ferreres Sole S, Ferrillo M, Ferro-Luzzi M, Filippov S, Fini RA, Fiorini M, Firlej M, Fischer KM, Fitzgerald DS, Fitzpatrick C, Fiutowski T, Fleuret F, Fontana M, Fontanelli F, Foreman LF, Forty R, Foulds-Holt D, Franco Sevilla M, Frank M, Franzoso E, Frau G, Frei C, Friday DA, Frontini L, Fu J, Fuehring Q, Fujii Y, Fulghesu T, Gabriel E, Galati G, Galati MD, Gallas Torreira A, Galli D, Gambetta S, Gandelman M, Gandini P, Gao H, Gao R, Gao Y, Gao Y, Gao Y, Garau M, Garcia Martin LM, Garcia Moreno P, García Pardiñas J, Garcia Plana B, Garg KG, Garrido L, Gaspar C, Geertsema RE, Gerken LL, Gersabeck E, Gersabeck M, Gershon T, Ghorbanimoghaddam Z, Giambastiani L, Giasemis FI, Gibson V, Giemza HK, Gilman AL, Giovannetti M, Gioventù A, Gironella Gironell P, Giugliano C, Giza MA, Gkougkousis EL, Glaser FC, Gligorov VV, Göbel C, Golobardes E, Golubkov D, Golutvin A, Gomes A, Gomez Fernandez S, Goncalves Abrantes F, Goncerz M, Gong G, Gooding JA, Gorelov IV, Gotti C, Grabowski JP, Granado Cardoso LA, Graugés E, Graverini E, Grazette L, Graziani G, Grecu AT, Greeven LM, Grieser NA, Grillo L, Gromov S, Gu C, Guarise M, Guittiere M, Guliaeva V, Günther PA, Guseinov AK, Gushchin E, Guz Y, Gys T, Hadavizadeh T, Hadjivasiliou C, Haefeli G, Haen C, Haimberger J, Hajheidari M, Halewood-Leagas T, Halvorsen MM, Hamilton PM, Hammerich J, Han Q, Han X, Hansmann-Menzemer S, Hao L, Harnew N, Harrison T, Hartmann M, Hasse C, He J, Heijhoff K, Hemmer F, Henderson C, Henderson RDL, Hennequin AM, Hennessy K, Henry L, Herd J, Heuel J, Hicheur A, Hill D, Hollitt SE, Horswill J, Hou R, Hou Y, Howarth N, Hu J, Hu J, Hu W, Hu X, Huang W, Hulsbergen W, Hunter RJ, Hushchyn M, Hutchcroft D, Idzik M, Ilin D, Ilten P, Inglessi A, Iniukhin A, Ishteev A, Ivshin K, Jacobsson R, Jage H, Jaimes Elles SJ, Jakobsen S, Jans E, Jashal BK, Jawahery A, Jevtic V, Jiang E, Jiang X, Jiang Y, Jiang YJ, John M, Johnson D, Jones CR, Jones TP, Joshi S, Jost B, Jurik N, Juszczak I, Kaminaris D, Kandybei S, Kang Y, Karacson M, Karpenkov D, Karpov M, Kauniskangas AM, Kautz JW, Keizer F, Keller DM, Kenzie M, Ketel T, Khanji B, Kharisova A, Kholodenko S, Khreich G, Kirn T, Kirsebom VS, Kitouni O, Klaver S, Kleijne N, Klimaszewski K, Kmiec MR, Koliiev S, Kolk L, Konoplyannikov A, Kopciewicz P, Koppenburg P, Korolev M, Kostiuk I, Kot O, Kotriakhova S, Kozachuk A, Kravchenko P, Kravchuk L, Kreps M, Kretzschmar S, Krokovny P, Krupa W, Krzemien W, Kubat J, Kubis S, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kulikova E, Kupsc A, Kutsenko BK, Lacarrere D, Lafferty G, Lai A, Lampis A, Lancierini D, Landesa Gomez C, Lane JJ, Lane R, Langenbruch C, Langer J, Lantwin O, Latham T, Lazzari F, Lazzeroni C, Le Gac R, Lee SH, Lefèvre R, Leflat A, Legotin S, Lehuraux M, Leroy O, Lesiak T, Leverington B, Li A, Li H, Li K, Li L, Li P, Li PR, Li S, Li T, Li T, Li Y, Li Y, Li Z, Lian Z, Liang X, Lin C, Lin T, Lindner R, Lisovskyi V, Litvinov R, Liu G, Liu H, Liu K, Liu Q, Liu S, Liu Y, Liu Y, Liu YL, Lobo Salvia A, Loi A, Lomba Castro J, Long T, Lopes JH, Lopez Huertas A, López Soliño S, Lovell GH, Lucarelli C, Lucchesi D, Luchuk S, Lucio Martinez M, Lukashenko V, Luo Y, Lupato A, Luppi E, Lynch K, Lyu XR, Ma GM, Ma R, Maccolini S, Machefert F, Maciuc F, Mackay I, Madhan Mohan LR, Madurai MM, Maevskiy A, Magdalinski D, Maisuzenko D, Majewski MW, Malczewski JJ, Malde S, Malecki B, Malentacca L, Malinin A, Maltsev T, Manca G, Mancinelli G, Mancuso C, Manera Escalero R, Manuzzi D, Marangotto D, Marchand JF, Marchevski R, Marconi U, Mariani S, Marin Benito C, Marks J, Marshall AM, Marshall PJ, Martelli G, Martellotti G, Martinazzoli L, Martinelli M, Martinez Santos D, Martinez Vidal F, Massafferri A, Materok M, Matev R, Mathad A, Matiunin V, Matteuzzi C, Mattioli KR, Mauri A, Maurice E, Mauricio J, Mayencourt P, Mazurek M, McCann M, Mcconnell L, McGrath TH, McHugh NT, McNab A, McNulty R, Meadows B, Meier G, Melnychuk D, Merk M, Merli A, Meyer Garcia L, Miao D, Miao H, Mikhasenko M, Milanes DA, Minotti A, Minucci E, Miralles T, Mitchell SE, Mitreska B, Mitzel DS, Modak A, Mödden A, Mohammed RA, Moise RD, Mokhnenko S, Mombächer T, Monk M, Monroy IA, Monteil S, Morcillo Gomez A, Morello G, Morello MJ, Morgenthaler MP, Moron J, Morris AB, Morris AG, Mountain R, Mu H, Mu ZM, Muhammad E, Muheim F, Mulder M, Müller K, Mũnoz-Rojas F, Murta R, Naik P, Nakada T, Nandakumar R, Nanut T, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neustroev P, Newcombe R, Nicolini J, Nicotra D, Niel EM, Nikitin N, Nogga P, Nolte NS, Normand C, Novoa Fernandez J, Nowak G, Nunez C, Nur HN, Oblakowska-Mucha A, Obraztsov V, Oeser T, Okamura S, Okhotnikov A, Oldeman R, Oliva F, Olocco M, Onderwater CJG, O'Neil RH, Otalora Goicochea JM, Ovsiannikova T, Owen P, Oyanguren A, Ozcelik O, Padeken KO, Pagare B, Pais PR, Pajero T, Palano A, Palutan M, Panshin G, Paolucci L, Papanestis A, Pappagallo M, Pappalardo LL, Pappenheimer C, Parkes C, Passalacqua B, Passaleva G, Passaro D, Pastore A, Patel M, Patoc J, Patrignani C, Pawley CJ, Pellegrino A, Pepe Altarelli M, Perazzini S, Pereima D, Pereiro Castro A, Perret P, Perro A, Petridis K, Petrolini A, Petrucci S, Pham H, Pica L, Piccini M, Pietrzyk B, Pietrzyk G, Pinci D, Pisani F, Pizzichemi M, Placinta V, Plo Casasus M, Polci F, Poli Lener M, Poluektov A, Polukhina N, Polyakov I, Polycarpo E, Ponce S, Popov D, Poslavskii S, Prasanth K, Promberger L, Prouve C, Pugatch V, Puill V, Punzi G, Qi HR, Qian W, Qin N, Qu S, Quagliani R, Rabadan Trejo RI, Rachwal B, Rademacker JH, Rama M, Ramírez García M, Ramos Pernas M, Rangel MS, Ratnikov F, Raven G, Rebollo De Miguel M, Redi F, Reich J, Reiss F, Ren Z, Resmi PK, Ribatti R, Ricart GR, Riccardi D, Ricciardi S, Richardson K, Richardson-Slipper M, Rinnert K, Robbe P, Robertson G, Rodrigues E, Rodriguez Fernandez E, Rodriguez Lopez JA, Rodriguez Rodriguez E, Rogovskiy A, Rolf DL, Rollings A, Roloff P, Romanovskiy V, Romero Lamas M, Romero Vidal A, Romolini G, Ronchetti F, Rotondo M, Roy SR, Rudolph MS, Ruf T, Ruiz Diaz M, Ruiz Fernandez RA, Ruiz Vidal J, Ryzhikov A, Ryzka J, Saborido Silva JJ, Sadek R, Sagidova N, Sahoo N, Saitta B, Salomoni M, Sanchez Gras C, Sanderswood I, Santacesaria R, Santamarina Rios C, Santimaria M, Santoro L, Santovetti E, Saputi A, Saranin D, Sarpis G, Sarpis M, Sarti A, Satriano C, Satta A, Saur M, Savrina D, Sazak H, Scantlebury Smead LG, Scarabotto A, Schael S, Scherl S, Schertz AM, Schiller M, Schindler H, Schmelling M, Schmidt B, Schmitt S, Schmitz H, Schneider O, Schopper A, Schulte N, Schulte S, Schune MH, Schwemmer R, Schwering G, Sciascia B, Sciuccati A, Sellam S, Semennikov A, Senghi Soares M, Sergi A, Serra N, Sestini L, Seuthe A, Shang Y, Shangase DM, Shapkin M, Shchemerov I, Shchutska L, Shears T, Shekhtman L, Shen Z, Sheng S, Shevchenko V, Shi B, Shields EB, Shimizu Y, Shmanin E, Shorkin R, Shupperd JD, Silva Coutinho R, Simi G, Simone S, Skidmore N, Skuza R, Skwarnicki T, Slater MW, Smallwood JC, Smith E, Smith K, Smith M, Snoch A, Soares Lavra L, Sokoloff MD, Soler FJP, Solomin A, Solovev A, Solovyev I, Song R, Song Y, Song Y, Song YS, Souza De Almeida FL, Souza De Paula B, Spadaro Norella E, Spedicato E, Speer JG, Spiridenkov E, Spradlin P, Sriskaran V, Stagni F, Stahl M, Stahl S, Stanislaus S, Stein EN, Steinkamp O, Stenyakin O, Stevens H, Strekalina D, Su Y, Suljik F, Sun J, Sun L, Sun Y, Swallow PN, Swientek K, Swystun F, Szabelski A, Szumlak T, Szymanski M, Tan Y, Taneja S, Tat MD, Terentev A, Terzuoli F, Teubert F, Thomas E, Thompson DJD, Tilquin H, Tisserand V, T'Jampens S, Tobin M, Tomassetti L, Tonani G, Tong X, Torres Machado D, Toscano L, Tou DY, Trippl C, Tuci G, Tuning N, Uecker LH, Ukleja A, Unverzagt DJ, Ursov E, Usachov A, Ustyuzhanin A, Uwer U, Vagnoni V, Valassi A, Valenti G, Valls Canudas N, Van Hecke H, van Herwijnen E, Van Hulse CB, Van Laak R, van Veghel M, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, Velthuis JJ, Veltri M, Venkateswaran A, Vesterinen M, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Vilella Figueras E, Villa A, Vincent P, Volle FC, Vom Bruch D, Vorobyev V, Voropaev N, Vos K, Vouters G, Vrahas C, Walsh J, Walton EJ, Wan G, Wang C, Wang G, Wang J, Wang J, Wang J, Wang J, Wang M, Wang NW, Wang R, Wang X, Wang XW, Wang Y, Wang Z, Wang Z, Wang Z, Ward JA, Watson NK, Websdale D, Wei Y, Westhenry BDC, White DJ, Whitehead M, Wiederhold AR, Wiedner D, Wilkinson G, Wilkinson MK, Williams M, Williams MRJ, Williams R, Wilson FF, Wislicki W, Witek M, Witola L, Wong CP, Wormser G, Wotton SA, Wu H, Wu J, Wu Y, Wyllie K, Xian S, Xiang Z, Xie Y, Xu A, Xu J, Xu L, Xu L, Xu M, Xu Z, Xu Z, Xu Z, Yang D, Yang S, Yang X, Yang Y, Yang Z, Yang Z, Yeroshenko V, Yeung H, Yin H, Yu CY, Yu J, Yuan X, Zaffaroni E, Zavertyaev M, Zdybal M, Zeng M, Zhang C, Zhang D, Zhang J, Zhang L, Zhang S, Zhang S, Zhang Y, Zhang Y, Zhang YZ, Zhao Y, Zharkova A, Zhelezov A, Zheng XZ, Zheng Y, Zhou T, Zhou X, Zhou Y, Zhovkovska V, Zhu LZ, Zhu X, Zhu X, Zhu Z, Zhukov V, Zhuo J, Zou Q, Zuliani D, Zunica G. Modification of χ_{c1}(3872) and ψ(2S) Production in pPb Collisions at sqrt[s_{NN}]=8.16 TeV. PHYSICAL REVIEW LETTERS 2024; 132:242301. [PMID: 38949352 DOI: 10.1103/physrevlett.132.242301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Accepted: 04/17/2024] [Indexed: 07/02/2024]
Abstract
The LHCb Collaboration measures production of the exotic hadron χ_{c1}(3872) in proton-nucleus collisions for the first time. Comparison with the charmonium state ψ(2S) suggests that the exotic χ_{c1}(3872) experiences different dynamics in the nuclear medium than conventional hadrons, and comparison with data from proton-proton collisions indicates that the presence of the nucleus may modify χ_{c1}(3872) production rates. This is the first measurement of the nuclear modification factor of an exotic hadron.
Collapse
|
4
|
Wang Z, Gao H, Wu D, Meng J, Deng J, Cui M. Defects and Defect Passivation in Perovskite Solar Cells. Molecules 2024; 29:2104. [PMID: 38731595 PMCID: PMC11085331 DOI: 10.3390/molecules29092104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Revised: 04/23/2024] [Accepted: 04/24/2024] [Indexed: 05/13/2024] Open
Abstract
Perovskite solar cells have made significant strides in recent years. However, there are still challenges in terms of photoelectric conversion efficiency and long-term stability associated with perovskite solar cells. The presence of defects in perovskite materials is one of the important influencing factors leading to subpar film quality. Adopting additives to passivate defects within perovskite materials is an effective approach. Therefore, we first discuss the types of defects that occur in perovskite materials and the mechanisms of their effect on performance. Then, several types of additives used in perovskite solar cells are discussed, including ionic compounds, organic molecules, polymers, etc. This review provides guidance for the future development of more sustainable and effective additives to improve the performance of solar cells.
Collapse
|
5
|
Deng J, Van Duyn C, Cohen DJ, Schwartz Z, Boyan BD. Strategies for Improving Impaired Osseointegration in Compromised Animal Models. J Dent Res 2024; 103:467-476. [PMID: 38616679 PMCID: PMC11055505 DOI: 10.1177/00220345241231777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/16/2024] Open
Abstract
Implant osseointegration is reduced in patients with systemic conditions that compromise bone quality, such as osteoporosis, disuse syndrome, and type 2 diabetes. Studies using rodent models designed to mimic these compromised conditions demonstrated reduced bone-to-implant contact (BIC) or a decline in bone mineral density. These adverse effects are a consequence of disrupted intercellular communication. A variety of approaches have been developed to compensate for the altered microenvironment inherent in compromised conditions, including the use of biologics and implant surface modification. Chemical and physical modification of surface properties at the microscale, mesoscale, and nanoscale levels to closely resemble the surface topography of osteoclast resorption pits found in bone has proven to be a highly effective strategy for improving implant osseointegration. The addition of hydrophilicity to the surface further enhances osteoblast response at the bone-implant interface. These surface modifications, applied either alone or in combination, improve osseointegration by increasing proliferation and osteoblastic differentiation of osteoprogenitor cells and enhancing angiogenesis while modulating osteoclast activity to achieve net new bone formation, although the specific effects vary with surface treatment. In addition to direct effects on surface-attached cells, the communication between bone marrow stromal cells and immunomodulatory cells is sensitive to these surface properties. This article reports on the advances in titanium surface modifications, alone and in combination with novel therapeutics in animal models of human disease affecting bone quality. It offers clinically translatable perspectives for clinicians to consider when using different surface modification strategies to improve long-term implant performance in compromised patients. This review supports the use of surface modifications, bioactive coatings, and localized therapeutics as pragmatic approaches to improve BIC and enhance osteogenic activity from both structural and molecular standpoints.
Collapse
|
6
|
Wang W, Deng J, Yin C, Wang F, Zhang C, Yu C, Gong S, Zhan X, Chen S, Shen D. Study of association between corneal shape parameters and axial length elongation during orthokeratology using image-pro plus software. BMC Ophthalmol 2024; 24:163. [PMID: 38609888 PMCID: PMC11010382 DOI: 10.1186/s12886-024-03398-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Accepted: 03/14/2024] [Indexed: 04/14/2024] Open
Abstract
BACKGROUND The aim was to validate the correlation between corneal shape parameters and axial length growth (ALG) during orthokeratology using Image-Pro Plus (IPP) 6.0 software. METHODS This retrospective study used medical records of myopic children aged 8-13 years (n = 104) undergoing orthokeratology. Their corneal topography and axial length were measured at baseline and subsequent follow-ups after lens wear. Corneal shape parameters, including the treatment zone (TZ) area, TZ diameter, TZ fractal dimension, TZ radius ratio, eccentric distance, pupil area, and pupillary peripheral steepened zone(PSZ) area, were measured using IPP software. The impact of corneal shape parameters at 3 months post-orthokeratology visit on 1.5-year ALG was evaluated using multivariate linear regression analysis. RESULTS ALG exhibited significant associations with age, TZ area, TZ diameter, TZ fractal dimension, and eccentric distance on univariate linear regression analysis. Multivariate regression analysis identified age, TZ area, and eccentric distance as significantly correlated with ALG (all P < 0.01), with eccentric distance showing the strongest correlation (β = -0.370). The regressive equation was y = 1.870 - 0.235a + 0.276b - 0.370c, where y represents ALG, a represents age, b represents TZ area, and c represents eccentric distance; R2 = 0.27). No significant relationships were observed between the TZ radius ratio, pupillary PSZ area, and ALG. CONCLUSIONS IPP software proves effective in capturing precise corneal shape parameters after orthokeratology. Eccentric distance, rather than age or the TZ area, significantly influences ALG retardation.
Collapse
|
7
|
Deng J, Lee M, Qin C, Lee Y, You M, Liu J. Protective behaviors against COVID-19 and their association with psychological factors in China and South Korea during the Omicron wave: a comparative study. Public Health 2024; 229:116-125. [PMID: 38428248 DOI: 10.1016/j.puhe.2024.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Revised: 01/24/2024] [Accepted: 02/01/2024] [Indexed: 03/03/2024]
Abstract
OBJECTIVES We aimed to explore the level of protective behaviors against COVID-19 and its association with psychological factors in China and South Korea during the Omicron wave. STUDY DESIGN Cross-sectional study. METHODS We conducted a population-based cross-sectional survey from March 15 to 30, 2023 in China and South Korea. Demographic characteristics, health status, protective behaviors, and psychological factors (including perceived risks, efficacy belief, attribution of disease, fear of COVID-19, trust and evaluation, fatalism, resilience, and pandemic fatigue) were investigated. After adjusting for sociodemographic and health-related factors, multivariable regression models were constructed to explore the psychological influencing factors of protective behavior. RESULTS A total of 3000 participants from China and 1000 participants from Korea were included in the final analysis. The mean performance score for protective behaviors among all respondents was 2.885 in China and 3.139 in Korea, with scores ranging from 1 to 4. In China, performance scores were higher in those who were female, aged 30-39, employed, married, living in urban areas, having the highest income level, having the best subjective health status, and having a history of chronic disease (P-value <0.05). In Korea, performance scores were higher for individuals who were female, over 50 years old, educated to high school or below, unemployed, married, had a history of chronic disease, and had never been infected with SARS-CoV-2 (P-value <0.05). In the multivariable regression model, perceived severity (β = 0.067), attribution of disease (β = 0.121), fear of COVID-19 (β = 0.128), trust and evaluation (β = 0.097), psychological resilience (β = 0.068), and efficacy belief (β = 0.216) were positively associated with the performance scores, pandemic fatigue (β = -0.089) was negatively associated with performance scores in China (P-value <0.05). However, in Korea, perceived susceptibility (β = 0.075), fear of COVID-19 (β = 0.107), and efficacy belief (β = 0.357) were positively associated with protective behaviors (P-value <0.05), trust and evaluation (β = -0.078) and pandemic fatigue (β = -0.063) were negatively associated with performance scores (P-value <0.05). CONCLUSIONS Populations in both China and Korea demonstrated great compliance with protective behaviors during the Omicron wave. Because of the sociocultural, economic, and political differences, there were differences in the association between psychological factors and protective behaviors in the two countries. This study, from the perspective of psychological factors in different cultural contexts, would provide references for increasing adherence to protective guidelines in future outbreaks of emerging infectious diseases.
Collapse
|
8
|
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adeva B, Adinolfi M, Adlarson P, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Alfonso Albero A, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreola P, Andreotti M, Andreou D, Anelli A, Ao D, Archilli F, Argenton M, Arguedas Cuendis S, Artamonov A, Artuso M, Aslanides E, Atzeni M, Audurier B, Bacher D, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Bailly-Reyre A, Baladron Rodriguez P, Balagura V, Baldini W, Baptista de Souza Leite J, Barbetti M, Barbosa IR, Barlow RJ, Barsuk S, Barter W, Bartolini M, Baryshnikov F, Basels JM, Bassi G, Batsukh B, Battig A, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Beiter A, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Bernstein HC, Bertella C, Bertolin A, Betancourt C, Betti F, Bex J, Bezshyiko I, Bhom J, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blago MP, Blake T, Blanc F, Blank JE, Blusk S, Bobulska D, Bocharnikov V, Boelhauve JA, Boente Garcia O, Boettcher T, Bohare A, Boldyrev A, Bolognani CS, Bolzonella R, Bondar N, Borgato F, Borghi S, Borsato M, Borsuk JT, Bouchiba SA, Bowcock TJV, Boyer A, Bozzi C, Bradley MJ, Braun S, Brea Rodriguez A, Breer N, Brodzicka J, Brossa Gonzalo A, Brown J, Brundu D, Buonaura A, Buonincontri L, Burke AT, Burr C, Bursche A, Butkevich A, Butter JS, Buytaert J, Byczynski W, Cadeddu S, Cai H, Calabrese R, Calefice L, Cali S, Calvi M, Calvo Gomez M, Cambon Bouzas J, Campana P, Campora Perez DH, Campoverde Quezada AF, Capelli S, Capriotti L, Caravaca-Mora R, Carbone A, Carcedo Salgado L, Cardinale R, Cardini A, Carniti P, Carus L, Casais Vidal A, Caspary R, Casse G, Castro Godinez J, Cattaneo M, Cavallero G, Cavallini V, Celani S, Cerasoli J, Cervenkov D, Cesare S, Chadwick AJ, Chahrour I, Charles M, Charpentier P, Chavez Barajas CA, Chefdeville M, Chen C, Chen S, Chernov A, Chernyshenko S, Chobanova V, Cholak S, Chrzaszcz M, Chubykin A, Chulikov V, Ciambrone P, Cicala MF, Cid Vidal X, Ciezarek G, Cifra P, Clarke PEL, Clemencic M, Cliff HV, Closier J, Cobbledick JL, Cocha Toapaxi C, Coco V, Cogan J, Cogneras E, Cojocariu L, Collins P, Colombo T, Comerma-Montells A, Congedo L, Contu A, Cooke N, Corredoira I, Correia A, Corti G, Cottee Meldrum JJ, Couturier B, Craik DC, Cruz Torres M, Currie R, Da Silva CL, Dadabaev S, Dai L, Dai X, Dall'Occo E, Dalseno J, D'Ambrosio C, Daniel J, Danilina A, d'Argent P, Davidson A, Davies JE, Davis A, De Aguiar Francisco O, De Angelis C, de Boer J, De Bruyn K, De Capua S, De Cian M, De Freitas Carneiro Da Graca U, De Lucia E, De Miranda JM, De Paula L, De Serio M, De Simone D, De Simone P, De Vellis F, de Vries JA, Debernardis F, Decamp D, Dedu V, Del Buono L, Delaney B, Dembinski HP, Deng J, Denysenko V, Deschamps O, Dettori F, Dey B, Di Nezza P, Diachkov I, Didenko S, Ding S, Dobishuk V, Docheva AD, Dolmatov A, Dong C, Donohoe AM, Dordei F, Dos Reis AC, Douglas L, Downes AG, Duan W, Duda P, Dudek MW, Dufour L, Duk V, Durante P, Duras MM, Durham JM, Dziurda A, Dzyuba A, Easo S, Eckstein E, Egede U, Egorychev A, Egorychev V, Eirea Orro C, Eisenhardt S, Ejopu E, Ek-In S, Eklund L, Elashri M, Ellbracht J, Ely S, Ene A, Epple E, Escher S, Eschle J, Esen S, Evans T, Fabiano F, Falcao LN, Fan Y, Fang B, Fantini L, Faria M, Farmer K, Fazzini D, Felkowski L, Feng M, Feo M, Fernandez Gomez M, Fernez AD, Ferrari F, Ferreira Rodrigues F, Ferreres Sole S, Ferrillo M, Ferro-Luzzi M, Filippov S, Fini RA, Fiorini M, Firlej M, Fischer KM, Fitzgerald DS, Fitzpatrick C, Fiutowski T, Fleuret F, Fontana M, Fontanelli F, Foreman LF, Forty R, Foulds-Holt D, Franco Sevilla M, Frank M, Franzoso E, Frau G, Frei C, Friday DA, Frontini L, Fu J, Fuehring Q, Fujii Y, Fulghesu T, Gabriel E, Galati G, Galati MD, Gallas Torreira A, Galli D, Gambetta S, Gandelman M, Gandini P, Gao H, Gao R, Gao Y, Gao Y, Gao Y, Garau M, Garcia Martin LM, Garcia Moreno P, García Pardiñas J, Garcia Plana B, Garg KG, Garrido L, Gaspar C, Geertsema RE, Gerken LL, Gersabeck E, Gersabeck M, Gershon T, Ghorbanimoghaddam Z, Giambastiani L, Giasemis FI, Gibson V, Giemza HK, Gilman AL, Giovannetti M, Gioventù A, Gironella Gironell P, Giugliano C, Giza MA, Gkougkousis EL, Glaser FC, Gligorov VV, Göbel C, Golobardes E, Golubkov D, Golutvin A, Gomes A, Gomez Fernandez S, Goncalves Abrantes F, Goncerz M, Gong G, Gooding JA, Gorelov IV, Gotti C, Grabowski JP, Granado Cardoso LA, Graugés E, Graverini E, Grazette L, Graziani G, Grecu AT, Greeven LM, Grieser NA, Grillo L, Gromov S, Gu C, Guarise M, Guittiere M, Guliaeva V, Günther PA, Guseinov AK, Gushchin E, Guz Y, Gys T, Hadavizadeh T, Hadjivasiliou C, Haefeli G, Haen C, Haimberger J, Hajheidari M, Halewood-Leagas T, Halvorsen MM, Hamilton PM, Hammerich J, Han Q, Han X, Hansmann-Menzemer S, Hao L, Harnew N, Harrison T, Hartmann M, Hasse C, He J, Heijhoff K, Hemmer F, Henderson C, Henderson RDL, Hennequin AM, Hennessy K, Henry L, Herd J, Herrero Gascon P, Heuel J, Hicheur A, Hill D, Hollitt SE, Horswill J, Hou R, Hou Y, Howarth N, Hu J, Hu J, Hu W, Hu X, Huang W, Hulsbergen W, Hunter RJ, Hushchyn M, Hutchcroft D, Idzik M, Ilin D, Ilten P, Inglessi A, Iniukhin A, Ishteev A, Ivshin K, Jacobsson R, Jage H, Jaimes Elles SJ, Jakobsen S, Jans E, Jashal BK, Jawahery A, Jevtic V, Jiang E, Jiang X, Jiang Y, Jiang YJ, John M, Johnson D, Jones CR, Jones TP, Joshi S, Jost B, Jurik N, Juszczak I, Kaminaris D, Kandybei S, Kang Y, Karacson M, Karpenkov D, Karpov M, Kauniskangas AM, Kautz JW, Keizer F, Keller DM, Kenzie M, Ketel T, Khanji B, Kharisova A, Kholodenko S, Khreich G, Kirn T, Kirsebom VS, Kitouni O, Klaver S, Kleijne N, Klimaszewski K, Kmiec MR, Koliiev S, Kolk L, Konoplyannikov A, Kopciewicz P, Koppenburg P, Korolev M, Kostiuk I, Kot O, Kotriakhova S, Kozachuk A, Kravchenko P, Kravchuk L, Kreps M, Kretzschmar S, Krokovny P, Krupa W, Krzemien W, Kubat J, Kubis S, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kulikova E, Kupsc A, Kutsenko BK, Lacarrere D, Lai A, Lampis A, Lancierini D, Landesa Gomez C, Lane JJ, Lane R, Langenbruch C, Langer J, Lantwin O, Latham T, Lazzari F, Lazzeroni C, Le Gac R, Lee SH, Lefèvre R, Leflat A, Legotin S, Lehuraux M, Leroy O, Lesiak T, Leverington B, Li A, Li H, Li K, Li L, Li P, Li PR, Li S, Li T, Li T, Li Y, Li Y, Li Z, Lian Z, Liang X, Lin C, Lin T, Lindner R, Lisovskyi V, Litvinov R, Liu G, Liu H, Liu K, Liu Q, Liu S, Liu Y, Liu Y, Liu YL, Lobo Salvia A, Loi A, Lomba Castro J, Long T, Lopes JH, Lopez Huertas A, López Soliño S, Lovell GH, Lucarelli C, Lucchesi D, Luchuk S, Lucio Martinez M, Lukashenko V, Luo Y, Lupato A, Luppi E, Lynch K, Lyu XR, Ma GM, Ma R, Maccolini S, Machefert F, Maciuc F, Mackay I, Madhan Mohan LR, Madurai MM, Maevskiy A, Magdalinski D, Maisuzenko D, Majewski MW, Malczewski JJ, Malde S, Malecki B, Malentacca L, Malinin A, Maltsev T, Manca G, Mancinelli G, Mancuso C, Manera Escalero R, Manuzzi D, Marangotto D, Marchand JF, Marchevski R, Marconi U, Mariani S, Marin Benito C, Marks J, Marshall AM, Marshall PJ, Martelli G, Martellotti G, Martinazzoli L, Martinelli M, Martinez Santos D, Martinez Vidal F, Massafferri A, Materok M, Matev R, Mathad A, Matiunin V, Matteuzzi C, Mattioli KR, Mauri A, Maurice E, Mauricio J, Mayencourt P, Mazurek M, McCann M, Mcconnell L, McGrath TH, McHugh NT, McNab A, McNulty R, Meadows B, Meier G, Melnychuk D, Merk M, Merli A, Meyer Garcia L, Miao D, Miao H, Mikhasenko M, Milanes DA, Minotti A, Minucci E, Miralles T, Mitchell SE, Mitreska B, Mitzel DS, Modak A, Mödden A, Mohammed RA, Moise RD, Mokhnenko S, Mombächer T, Monk M, Monroy IA, Monteil S, Morcillo Gomez A, Morello G, Morello MJ, Morgenthaler MP, Moron J, Morris AB, Morris AG, Mountain R, Mu H, Mu ZM, Muhammad E, Muheim F, Mulder M, Müller K, Muñoz-Rojas F, Murta R, Naik P, Nakada T, Nandakumar R, Nanut T, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neustroev P, Newcombe R, Nicolini J, Nicotra D, Niel EM, Nikitin N, Nogga P, Nolte NS, Normand C, Novoa Fernandez J, Nowak G, Nunez C, Nur HN, Oblakowska-Mucha A, Obraztsov V, Oeser T, Okamura S, Oldeman R, Oliva F, Olocco M, Onderwater CJG, O'Neil RH, Otalora Goicochea JM, Ovsiannikova T, Owen P, Oyanguren A, Ozcelik O, Padeken KO, Pagare B, Pais PR, Pajero T, Palano A, Palutan M, Panshin G, Paolucci L, Papanestis A, Pappagallo M, Pappalardo LL, Pappenheimer C, Parkes C, Passalacqua B, Passaleva G, Passaro D, Pastore A, Patel M, Patoc J, Patrignani C, Pawley CJ, Pellegrino A, Pepe Altarelli M, Perazzini S, Pereima D, Pereiro Castro A, Perret P, Perro A, Petridis K, Petrolini A, Petrucci S, Pham H, Pica L, Piccini M, Pietrzyk B, Pietrzyk G, Pinci D, Pisani F, Pizzichemi M, Placinta V, Plo Casasus M, Polci F, Poli Lener M, Poluektov A, Polukhina N, Polyakov I, Polycarpo E, Ponce S, Popov D, Poslavskii S, Prasanth K, Prouve C, Pugatch V, Puill V, Punzi G, Qi HR, Qian W, Qin N, Qu S, Quagliani R, Rabadan Trejo RI, Rachwal B, Rademacker JH, Rama M, Ramírez García M, Ramos Pernas M, Rangel MS, Ratnikov F, Raven G, Rebollo De Miguel M, Redi F, Reich J, Reiss F, Ren Z, Resmi PK, Ribatti R, Ricart GR, Riccardi D, Ricciardi S, Richardson K, Richardson-Slipper M, Rinnert K, Robbe P, Robertson G, Rodrigues E, Rodriguez Fernandez E, Rodriguez Lopez JA, Rodriguez Rodriguez E, Rogovskiy A, Rolf DL, Rollings A, Roloff P, Romanovskiy V, Romero Lamas M, Romero Vidal A, Romolini G, Ronchetti F, Rotondo M, Roy SR, Rudolph MS, Ruf T, Ruiz Diaz M, Ruiz Fernandez RA, Ruiz Vidal J, Ryzhikov A, Ryzka J, Saborido Silva JJ, Sadek R, Sagidova N, Sahoo N, Saitta B, Salomoni M, Sanchez Gras C, Sanderswood I, Santacesaria R, Santamarina Rios C, Santimaria M, Santoro L, Santovetti E, Saputi A, Saranin D, Sarpis G, Sarpis M, Sarti A, Satriano C, Satta A, Saur M, Savrina D, Sazak H, Scantlebury Smead LG, Scarabotto A, Schael S, Scherl S, Schertz AM, Schiller M, Schindler H, Schmelling M, Schmidt B, Schmitt S, Schmitz H, Schneider O, Schopper A, Schulte N, Schulte S, Schune MH, Schwemmer R, Schwering G, Sciascia B, Sciuccati A, Sellam S, Semennikov A, Senghi Soares M, Sergi A, Serra N, Sestini L, Seuthe A, Shang Y, Shangase DM, Shapkin M, Shchemerov I, Shchutska L, Shears T, Shekhtman L, Shen Z, Sheng S, Shevchenko V, Shi B, Shields EB, Shimizu Y, Shmanin E, Shorkin R, Shupperd JD, Silva Coutinho R, Simi G, Simone S, Skidmore N, Skuza R, Skwarnicki T, Slater MW, Smallwood JC, Smith E, Smith K, Smith M, Snoch A, Soares Lavra L, Sokoloff MD, Soler FJP, Solomin A, Solovev A, Solovyev I, Song R, Song Y, Song Y, Song YS, Souza De Almeida FL, Souza De Paula B, Spadaro Norella E, Spedicato E, Speer JG, Spiridenkov E, Spradlin P, Sriskaran V, Stagni F, Stahl M, Stahl S, Stanislaus S, Stein EN, Steinkamp O, Stenyakin O, Stevens H, Strekalina D, Su Y, Suljik F, Sun J, Sun L, Sun Y, Swallow PN, Swientek K, Swystun F, Szabelski A, Szumlak T, Szymanski M, Tan Y, Taneja S, Tat MD, Terentev A, Terzuoli F, Teubert F, Thomas E, Thompson DJD, Tilquin H, Tisserand V, T'Jampens S, Tobin M, Tomassetti L, Tonani G, Tong X, Torres Machado D, Toscano L, Tou DY, Trippl C, Tuci G, Tuning N, Uecker LH, Ukleja A, Unverzagt DJ, Ursov E, Usachov A, Ustyuzhanin A, Uwer U, Vagnoni V, Valassi A, Valenti G, Valls Canudas N, Van Hecke H, van Herwijnen E, Van Hulse CB, Van Laak R, van Veghel M, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, Velthuis JJ, Veltri M, Venkateswaran A, Vesterinen M, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Vilella Figueras E, Villa A, Vincent P, Volle FC, Vom Bruch D, Vorobyev V, Voropaev N, Vos K, Vouters G, Vrahas C, Walsh J, Walton EJ, Wan G, Wang C, Wang G, Wang J, Wang J, Wang J, Wang J, Wang M, Wang NW, Wang R, Wang X, Wang XW, Wang Y, Wang Z, Wang Z, Wang Z, Ward JA, Watson NK, Websdale D, Wei Y, Westhenry BDC, White DJ, Whitehead M, Wiederhold AR, Wiedner D, Wilkinson G, Wilkinson MK, Williams M, Williams MRJ, Williams R, Wilson FF, Wislicki W, Witek M, Witola L, Wong CP, Wormser G, Wotton SA, Wu H, Wu J, Wu Y, Wyllie K, Xian S, Xiang Z, Xie Y, Xu A, Xu J, Xu L, Xu L, Xu M, Xu Z, Xu Z, Xu Z, Yang D, Yang S, Yang X, Yang Y, Yang Z, Yang Z, Yeroshenko V, Yeung H, Yin H, Yu CY, Yu J, Yuan X, Zaffaroni E, Zavertyaev M, Zdybal M, Zeng M, Zhang C, Zhang D, Zhang J, Zhang L, Zhang S, Zhang S, Zhang Y, Zhang Y, Zhang YZ, Zhao Y, Zharkova A, Zhelezov A, Zheng XZ, Zheng Y, Zhou T, Zhou X, Zhou Y, Zhovkovska V, Zhu LZ, Zhu X, Zhu X, Zhu Z, Zhukov V, Zhuo J, Zou Q, Zuliani D, Zunica G. Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay. PHYSICAL REVIEW LETTERS 2024; 132:131801. [PMID: 38613276 DOI: 10.1103/physrevlett.132.131801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/15/2023] [Accepted: 01/26/2024] [Indexed: 04/14/2024]
Abstract
An amplitude analysis of the B^{0}→K^{*0}μ^{+}μ^{-} decay is presented using a dataset corresponding to an integrated luminosity of 4.7 fb^{-1} of pp collision data collected with the LHCb experiment. For the first time, the coefficients associated to short-distance physics effects, sensitive to processes beyond the standard model, are extracted directly from the data through a q^{2}-unbinned amplitude analysis, where q^{2} is the μ^{+}μ^{-} invariant mass squared. Long-distance contributions, which originate from nonfactorizable QCD processes, are systematically investigated, and the most accurate assessment to date of their impact on the physical observables is obtained. The pattern of measured corrections to the short-distance couplings is found to be consistent with previous analyses of b- to s-quark transitions, with the largest discrepancy from the standard model predictions found to be at the level of 1.8 standard deviations. The global significance of the observed differences in the decay is 1.4 standard deviations.
Collapse
|
9
|
Deng J, Xu XZ, Ye X, Chen YK, Ding HQ, Liu J, Xia WJ, Chen DW, Xu YR. [Pathogenetic analysis of transfusion-related acute lung injury caused by human leukocytes antigen antibody against human leukocyte antigen]. ZHONGHUA YI XUE ZA ZHI 2024; 104:883-887. [PMID: 38462366 DOI: 10.3760/cma.j.cn112137-20231201-01263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/12/2024]
Abstract
From September 2019 to October 2020, pathogenetic analysis of three patients clinically diagnosed as transfusion-related acute lung injury (TRALI) caused by human leukocyte antibodies was conducted by Guangzhou Blood Centre, including 2 males and 1 female, aged 56, 50 and 20 years old, respectively. Solid phase agglutination, anti-human globulin test and flow cytometry method were used to detect the presence of antibodies against patients. Sequencing-based human leukocyte antigen (HLA-SBT) typing technique was used to detect the human leukocyte antigen (HLA) genotypes of patients. Lifecodes single antigen class Ⅰ/Ⅱ kit (LSA-Ⅰ/Ⅱ) were used to detect the specificity of HLA-class Ⅰ and class Ⅱ antibodies in donor blood by Luminex 200 liquid suspension chip system. The HLA specific antibodies and corresponding epitopes in donors were also analyzed. The results showed that HLA class Ⅰ or class Ⅱ specific antibodies against TRALI patients were detected in the blood donors. The plasma of donor 3 received by patient 1 contained antibodies against the patient's HLA-DRB1*09∶01 antigen, and the epitopes mediating the antibody reaction of the donor and recipient were 70R, 31I, 70QA. There were antibodies against the HLA-A*11∶02, HLA-A*11∶01, DRB1*12∶02, and DRB1*09∶01 antigens of patient 2 in the plasma of donor 4, and the associated antigenic epitopes were 151AHA, 57V, and 16Y. Antibodies against the HLA-DRB1*14∶04, DRB1*11∶01, and DPB1*05∶01 antigens of patient 3 were present in the plasma of donor 6 and donor 7, and the associated epitopes were 96HK, 140TV, 13SE, and 111K. Three cases of TRALI were confirmed to be caused by HLA antibodies through laboratory analysis, and human leukocyte antibody detection should be paid attention in clinically suspected cases of TRALI, and targeted diagnosis and treatment should be given.
Collapse
|
10
|
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adeva B, Adinolfi M, Adlarson P, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Alfonso Albero A, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreola P, Andreotti M, Andreou D, Anelli AA, Ao D, Archilli F, Argenton M, Arguedas Cuendis S, Artamonov A, Artuso M, Aslanides E, Atzeni M, Audurier B, Bacher D, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Bailly-Reyre A, Baladron Rodriguez P, Balagura V, Baldini W, Baptista de Souza Leite J, Barbetti M, Barbosa IR, Barlow RJ, Barsuk S, Barter W, Bartolini M, Baryshnikov F, Basels JM, Bassi G, Batsukh B, Battig A, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Beiter A, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Bernstein HC, Bertella C, Bertolin A, Betancourt C, Betti F, Bex J, Bezshyiko I, Bhom J, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blago MP, Blake T, Blanc F, Blank JE, Blusk S, Bobulska D, Bocharnikov V, Boelhauve JA, Boente Garcia O, Boettcher T, Bohare A, Boldyrev A, Bolognani CS, Bolzonella R, Bondar N, Borgato F, Borghi S, Borsato M, Borsuk JT, Bouchiba SA, Bowcock TJV, Boyer A, Bozzi C, Bradley MJ, Braun S, Brea Rodriguez A, Breer N, Brodzicka J, Brossa Gonzalo A, Brown J, Brundu D, Buonaura A, Buonincontri L, Burke AT, Burr C, Bursche A, Butkevich A, Butter JS, Buytaert J, Byczynski W, Cadeddu S, Cai H, Calabrese R, Calefice L, Cali S, Calvi M, Calvo Gomez M, Cambon Bouzas J, Campana P, Campora Perez DH, Campoverde Quezada AF, Capelli S, Capriotti L, Caravaca-Mora R, Carbone A, Carcedo Salgado L, Cardinale R, Cardini A, Carniti P, Carus L, Casais Vidal A, Caspary R, Casse G, Castro Godinez J, Cattaneo M, Cavallero G, Cavallini V, Celani S, Cerasoli J, Cervenkov D, Cesare S, Chadwick AJ, Chahrour I, Charles M, Charpentier P, Chavez Barajas CA, Chefdeville M, Chen C, Chen S, Chernov A, Chernyshenko S, Chobanova V, Cholak S, Chrzaszcz M, Chubykin A, Chulikov V, Ciambrone P, Cicala MF, Cid Vidal X, Ciezarek G, Cifra P, Clarke PEL, Clemencic M, Cliff HV, Closier J, Cobbledick JL, Cocha Toapaxi C, Coco V, Cogan J, Cogneras E, Cojocariu L, Collins P, Colombo T, Comerma-Montells A, Congedo L, Contu A, Cooke N, Corredoira I, Correia A, Corti G, Cottee Meldrum JJ, Couturier B, Craik DC, Cruz Torres M, Currie R, Da Silva CL, Dadabaev S, Dai L, Dai X, Dall'Occo E, Dalseno J, D'Ambrosio C, Daniel J, Danilina A, d'Argent P, Davidson A, Davies JE, Davis A, De Aguiar Francisco O, De Angelis C, de Boer J, De Bruyn K, De Capua S, De Cian M, De Freitas Carneiro Da Graca U, De Lucia E, De Miranda JM, De Paula L, De Serio M, De Simone D, De Simone P, De Vellis F, de Vries JA, Debernardis F, Decamp D, Dedu V, Del Buono L, Delaney B, Dembinski HP, Deng J, Denysenko V, Deschamps O, Dettori F, Dey B, Di Nezza P, Diachkov I, Didenko S, Ding S, Dobishuk V, Docheva AD, Dolmatov A, Dong C, Donohoe AM, Dordei F, Dos Reis AC, Douglas L, Downes AG, Duan W, Duda P, Dudek MW, Dufour L, Duk V, Durante P, Duras MM, Durham JM, Dziurda A, Dzyuba A, Easo S, Eckstein E, Egede U, Egorychev A, Egorychev V, Eirea Orro C, Eisenhardt S, Ejopu E, Ek-In S, Eklund L, Elashri M, Ellbracht J, Ely S, Ene A, Epple E, Escher S, Eschle J, Esen S, Evans T, Fabiano F, Falcao LN, Fan Y, Fang B, Fantini L, Faria M, Farmer K, Fazzini D, Felkowski L, Feng M, Feo M, Fernandez Gomez M, Fernez AD, Ferrari F, Ferreira Rodrigues F, Ferreres Sole S, Ferrillo M, Ferro-Luzzi M, Filippov S, Fini RA, Fiorini M, Firlej M, Fischer KM, Fitzgerald DS, Fitzpatrick C, Fiutowski T, Fleuret F, Fontana M, Fontanelli F, Foreman LF, Forty R, Foulds-Holt D, Franco Sevilla M, Frank M, Franzoso E, Frau G, Frei C, Friday DA, Frontini L, Fu J, Fuehring Q, Fujii Y, Fulghesu T, Gabriel E, Galati G, Galati MD, Gallas Torreira A, Galli D, Gambetta S, Gandelman M, Gandini P, Gao H, Gao R, Gao Y, Gao Y, Gao Y, Garau M, Garcia Martin LM, Garcia Moreno P, García Pardiñas J, Garcia Plana B, Garg KG, Garrido L, Gaspar C, Geertsema RE, Gerken LL, Gersabeck E, Gersabeck M, Gershon T, Ghorbanimoghaddam Z, Giambastiani L, Giasemis FI, Gibson V, Giemza HK, Gilman AL, Giovannetti M, Gioventù A, Gironella Gironell P, Giugliano C, Giza MA, Gkougkousis EL, Glaser FC, Gligorov VV, Göbel C, Golobardes E, Golubkov D, Golutvin A, Gomes A, Gomez Fernandez S, Goncalves Abrantes F, Goncerz M, Gong G, Gooding JA, Gorelov IV, Gotti C, Grabowski JP, Granado Cardoso LA, Graugés E, Graverini E, Grazette L, Graziani G, Grecu AT, Greeven LM, Grieser NA, Grillo L, Gromov S, Gu C, Guarise M, Guittiere M, Guliaeva V, Günther PA, Guseinov AK, Gushchin E, Guz Y, Gys T, Hadavizadeh T, Hadjivasiliou C, Haefeli G, Haen C, Haimberger J, Hajheidari M, Halewood-Leagas T, Halvorsen MM, Hamilton PM, Hammerich J, Han Q, Han X, Hansmann-Menzemer S, Hao L, Harnew N, Harrison T, Hartmann M, Hasse C, He J, Heijhoff K, Hemmer F, Henderson C, Henderson RDL, Hennequin AM, Hennessy K, Henry L, Herd J, Heuel J, Hicheur A, Hill D, Hollitt SE, Horswill J, Hou R, Hou Y, Howarth N, Hu J, Hu J, Hu W, Hu X, Huang W, Hulsbergen W, Hunter RJ, Hushchyn M, Hutchcroft D, Idzik M, Ilin D, Ilten P, Inglessi A, Iniukhin A, Ishteev A, Ivshin K, Jacobsson R, Jage H, Jaimes Elles SJ, Jakobsen S, Jans E, Jashal BK, Jawahery A, Jevtic V, Jiang E, Jiang X, Jiang Y, Jiang YJ, John M, Johnson D, Jones CR, Jones TP, Joshi S, Jost B, Jurik N, Juszczak I, Kaminaris D, Kandybei S, Kang Y, Karacson M, Karpenkov D, Karpov M, Kauniskangas AM, Kautz JW, Keizer F, Keller DM, Kenzie M, Ketel T, Khanji B, Kharisova A, Kholodenko S, Khreich G, Kirn T, Kirsebom VS, Kitouni O, Klaver S, Kleijne N, Klimaszewski K, Kmiec MR, Koliiev S, Kolk L, Konoplyannikov A, Kopciewicz P, Koppenburg P, Korolev M, Kostiuk I, Kot O, Kotriakhova S, Kozachuk A, Kravchenko P, Kravchuk L, Kreps M, Kretzschmar S, Krokovny P, Krupa W, Krzemien W, Kubat J, Kubis S, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kulikova E, Kupsc A, Kutsenko BK, Lacarrere D, Lai A, Lampis A, Lancierini D, Landesa Gomez C, Lane JJ, Lane R, Langenbruch C, Langer J, Lantwin O, Latham T, Lazzari F, Lazzeroni C, Le Gac R, Lee SH, Lefèvre R, Leflat A, Legotin S, Lehuraux M, Leroy O, Lesiak T, Leverington B, Li A, Li H, Li K, Li L, Li P, Li PR, Li S, Li T, Li T, Li Y, Li Y, Li Z, Lian Z, Liang X, Lin C, Lin T, Lindner R, Lisovskyi V, Litvinov R, Liu G, Liu H, Liu K, Liu Q, Liu S, Liu Y, Liu Y, Liu YL, Lobo Salvia A, Loi A, Lomba Castro J, Long T, Lopes JH, Lopez Huertas A, López Soliño S, Lovell GH, Lucarelli C, Lucchesi D, Luchuk S, Lucio Martinez M, Lukashenko V, Luo Y, Lupato A, Luppi E, Lynch K, Lyu XR, Ma GM, Ma R, Maccolini S, Machefert F, Maciuc F, Mackay I, Madhan Mohan LR, Madurai MM, Maevskiy A, Magdalinski D, Maisuzenko D, Majewski MW, Malczewski JJ, Malde S, Malecki B, Malentacca L, Malinin A, Maltsev T, Manca G, Mancinelli G, Mancuso C, Manera Escalero R, Manuzzi D, Marangotto D, Marchand JF, Marchevski R, Marconi U, Mariani S, Marin Benito C, Marks J, Marshall AM, Marshall PJ, Martelli G, Martellotti G, Martinazzoli L, Martinelli M, Martinez Santos D, Martinez Vidal F, Massafferri A, Materok M, Matev R, Mathad A, Matiunin V, Matteuzzi C, Mattioli KR, Mauri A, Maurice E, Mauricio J, Mayencourt P, Mazurek M, McCann M, Mcconnell L, McGrath TH, McHugh NT, McNab A, McNulty R, Meadows B, Meier G, Melnychuk D, Merk M, Merli A, Meyer Garcia L, Miao D, Miao H, Mikhasenko M, Milanes DA, Minotti A, Minucci E, Miralles T, Mitchell SE, Mitreska B, Mitzel DS, Modak A, Mödden A, Mohammed RA, Moise RD, Mokhnenko S, Mombächer T, Monk M, Monroy IA, Monteil S, Morcillo Gomez A, Morello G, Morello MJ, Morgenthaler MP, Moron J, Morris AB, Morris AG, Mountain R, Mu H, Mu ZM, Muhammad E, Muheim F, Mulder M, Müller K, Mũnoz-Rojas F, Murta R, Naik P, Nakada T, Nandakumar R, Nanut T, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neustroev P, Newcombe R, Nicolini J, Nicotra D, Niel EM, Nikitin N, Nogga P, Nolte NS, Normand C, Novoa Fernandez J, Nowak G, Nunez C, Nur HN, Oblakowska-Mucha A, Obraztsov V, Oeser T, Okamura S, Oldeman R, Oliva F, Olocco M, Onderwater CJG, O'Neil RH, Otalora Goicochea JM, Ovsiannikova T, Owen P, Oyanguren A, Ozcelik O, Padeken KO, Pagare B, Pais PR, Pajero T, Palano A, Palutan M, Panshin G, Paolucci L, Papanestis A, Pappagallo M, Pappalardo LL, Pappenheimer C, Parkes C, Passalacqua B, Passaleva G, Passaro D, Pastore A, Patel M, Patoc J, Patrignani C, Pawley CJ, Pellegrino A, Pepe Altarelli M, Perazzini S, Pereima D, Pereiro Castro A, Perret P, Perro A, Petridis K, Petrolini A, Petrucci S, Pham H, Pica L, Piccini M, Pietrzyk B, Pietrzyk G, Pinci D, Pisani F, Pizzichemi M, Placinta V, Plo Casasus M, Polci F, Poli Lener M, Poluektov A, Polukhina N, Polyakov I, Polycarpo E, Ponce S, Popov D, Poslavskii S, Prasanth K, Prouve C, Pugatch V, Puill V, Punzi G, Qi HR, Qian W, Qin N, Qu S, Quagliani R, Rabadan Trejo RI, Rachwal B, Rademacker JH, Rama M, Ramírez García M, Ramos Pernas M, Rangel MS, Ratnikov F, Raven G, Rebollo De Miguel M, Redi F, Reich J, Reiss F, Ren Z, Resmi PK, Ribatti R, Ricart GR, Riccardi D, Ricciardi S, Richardson K, Richardson-Slipper M, Rinnert K, Robbe P, Robertson G, Rodrigues E, Rodriguez Fernandez E, Rodriguez Lopez JA, Rodriguez Rodriguez E, Rogovskiy A, Rolf DL, Rollings A, Roloff P, Romanovskiy V, Romero Lamas M, Romero Vidal A, Romolini G, Ronchetti F, Rotondo M, Roy SR, Rudolph MS, Ruf T, Ruiz Diaz M, Ruiz Fernandez RA, Ruiz Vidal J, Ryzhikov A, Ryzka J, Saborido Silva JJ, Sadek R, Sagidova N, Sahoo N, Saitta B, Salomoni M, Sanchez Gras C, Sanderswood I, Santacesaria R, Santamarina Rios C, Santimaria M, Santoro L, Santovetti E, Saputi A, Saranin D, Sarpis G, Sarpis M, Sarti A, Satriano C, Satta A, Saur M, Savrina D, Sazak H, Scantlebury Smead LG, Scarabotto A, Schael S, Scherl S, Schertz AM, Schiller M, Schindler H, Schmelling M, Schmidt B, Schmitt S, Schmitz H, Schneider O, Schopper A, Schulte N, Schulte S, Schune MH, Schwemmer R, Schwering G, Sciascia B, Sciuccati A, Sellam S, Semennikov A, Senghi Soares M, Sergi A, Serra N, Sestini L, Seuthe A, Shang Y, Shangase DM, Shapkin M, Shchemerov I, Shchutska L, Shears T, Shekhtman L, Shen Z, Sheng S, Shevchenko V, Shi B, Shields EB, Shimizu Y, Shmanin E, Shorkin R, Shupperd JD, Silva Coutinho R, Simi G, Simone S, Skidmore N, Skuza R, Skwarnicki T, Slater MW, Smallwood JC, Smith E, Smith K, Smith M, Snoch A, Soares Lavra L, Sokoloff MD, Soler FJP, Solomin A, Solovev A, Solovyev I, Song R, Song Y, Song Y, Song YS, Souza De Almeida FL, Souza De Paula B, Spadaro Norella E, Spedicato E, Speer JG, Spiridenkov E, Spradlin P, Sriskaran V, Stagni F, Stahl M, Stahl S, Stanislaus S, Stein EN, Steinkamp O, Stenyakin O, Stevens H, Strekalina D, Su Y, Suljik F, Sun J, Sun L, Sun Y, Swallow PN, Swientek K, Swystun F, Szabelski A, Szumlak T, Szymanski M, Tan Y, Taneja S, Tat MD, Terentev A, Terzuoli F, Teubert F, Thomas E, Thompson DJD, Tilquin H, Tisserand V, T'Jampens S, Tobin M, Tomassetti L, Tonani G, Tong X, Torres Machado D, Toscano L, Tou DY, Trippl C, Tuci G, Tuning N, Uecker LH, Ukleja A, Unverzagt DJ, Ursov E, Usachov A, Ustyuzhanin A, Uwer U, Vagnoni V, Valassi A, Valenti G, Valls Canudas N, Van Hecke H, van Herwijnen E, Van Hulse CB, Van Laak R, van Veghel M, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, Velthuis JJ, Veltri M, Venkateswaran A, Vesterinen M, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Vilella Figueras E, Villa A, Vincent P, Volle FC, Vom Bruch D, Vorobyev V, Voropaev N, Vos K, Vouters G, Vrahas C, Walsh J, Walton EJ, Wan G, Wang C, Wang G, Wang J, Wang J, Wang J, Wang J, Wang M, Wang NW, Wang R, Wang X, Wang XW, Wang Y, Wang Z, Wang Z, Wang Z, Ward JA, Watson NK, Websdale D, Wei Y, Westhenry BDC, White DJ, Whitehead M, Wiederhold AR, Wiedner D, Wilkinson G, Wilkinson MK, Williams M, Williams MRJ, Williams R, Wilson FF, Wislicki W, Witek M, Witola L, Wong CP, Wormser G, Wotton SA, Wu H, Wu J, Wu Y, Wyllie K, Xian S, Xiang Z, Xie Y, Xu A, Xu J, Xu L, Xu L, Xu M, Xu Z, Xu Z, Xu Z, Yang D, Yang S, Yang X, Yang Y, Yang Z, Yang Z, Yeroshenko V, Yeung H, Yin H, Yu CY, Yu J, Yuan X, Zaffaroni E, Zavertyaev M, Zdybal M, Zeng M, Zhang C, Zhang D, Zhang J, Zhang L, Zhang S, Zhang S, Zhang Y, Zhang Y, Zhang YZ, Zhao Y, Zharkova A, Zhelezov A, Zheng XZ, Zheng Y, Zhou T, Zhou X, Zhou Y, Zhovkovska V, Zhu LZ, Zhu X, Zhu X, Zhu Z, Zhukov V, Zhuo J, Zou Q, Zuliani D, Zunica G. Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16 TeV. PHYSICAL REVIEW LETTERS 2024; 132:102302. [PMID: 38518337 DOI: 10.1103/physrevlett.132.102302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 01/05/2024] [Accepted: 02/06/2024] [Indexed: 03/24/2024]
Abstract
The fraction of χ_{c1} and χ_{c2} decays in the prompt J/ψ yield, F_{χ_{c}→J/ψ}=σ_{χ_{c}→J/ψ}/σ_{J/ψ}, is measured by the LHCb detector in pPb collisions at sqrt[s_{NN}]=8.16 TeV. The study covers the forward (1.5
Collapse
|
11
|
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adeva B, Adinolfi M, Adlarson P, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Alfonso Albero A, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreola P, Andreotti M, Andreou D, Anelli AA, Ao D, Archilli F, Argenton M, Arguedas Cuendis S, Artamonov A, Artuso M, Aslanides E, Atzeni M, Audurier B, Bacher D, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Bailly-Reyre A, Baladron Rodriguez P, Balagura V, Baldini W, Baptista de Souza Leite J, Barbetti M, Barbosa IR, Barlow RJ, Barsuk S, Barter W, Bartolini M, Baryshnikov F, Basels JM, Bassi G, Batsukh B, Battig A, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Beiter A, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Berkey JLM, Bernet R, Bernet Andres S, Bernstein HC, Bertella C, Bertolin A, Betancourt C, Betti F, Bex J, Bezshyiko I, Bhom J, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blago MP, Blake T, Blanc F, Blank JE, Blusk S, Bobulska D, Bocharnikov V, Boelhauve JA, Boente Garcia O, Boettcher T, Bohare A, Boldyrev A, Bolognani CS, Bolzonella R, Bondar N, Borgato F, Borghi S, Borsato M, Borsuk JT, Bouchiba SA, Bowcock TJV, Boyer A, Bozzi C, Bradley MJ, Braun S, Brea Rodriguez A, Breer N, Brodzicka J, Brossa Gonzalo A, Brown J, Brundu D, Buonaura A, Buonincontri L, Burke AT, Burr C, Bursche A, Butkevich A, Butter JS, Buytaert J, Byczynski W, Cadeddu S, Cai H, Calabrese R, Calefice L, Cali S, Calvi M, Calvo Gomez M, Cambon Bouzas J, Campana P, Campora Perez DH, Campoverde Quezada AF, Capelli S, Capriotti L, Caravaca-Mora R, Carbone A, Carcedo Salgado L, Cardinale R, Cardini A, Carniti P, Carus L, Casais Vidal A, Caspary R, Casse G, Castro Godinez J, Cattaneo M, Cavallero G, Cavallini V, Celani S, Cerasoli J, Cervenkov D, Cesare S, Chadwick AJ, Chahrour I, Charles M, Charpentier P, Chavez Barajas CA, Chefdeville M, Chen C, Chen S, Chernov A, Chernyshenko S, Chobanova V, Cholak S, Chrzaszcz M, Chubykin A, Chulikov V, Ciambrone P, Cicala MF, Cid Vidal X, Ciezarek G, Cifra P, Clarke PEL, Clemencic M, Cliff HV, Closier J, Cobbledick JL, Cocha Toapaxi C, Coco V, Cogan J, Cogneras E, Cojocariu L, Collins P, Colombo T, Comerma-Montells A, Congedo L, Contu A, Cooke N, Corredoira I, Correia A, Corti G, Cottee Meldrum JJ, Couturier B, Craik DC, Cruz Torres M, Currie R, Da Silva CL, Dadabaev S, Dai L, Dai X, Dall'Occo E, Dalseno J, D'Ambrosio C, Daniel J, Danilina A, d'Argent P, Davidson A, Davies JE, Davis A, De Aguiar Francisco O, De Angelis C, de Boer J, De Bruyn K, De Capua S, De Cian M, De Freitas Carneiro Da Graca U, De Lucia E, De Miranda JM, De Paula L, De Serio M, De Simone D, De Simone P, De Vellis F, de Vries JA, Debernardis F, Decamp D, Dedu V, Del Buono L, Delaney B, Dembinski HP, Deng J, Denysenko V, Deschamps O, Dettori F, Dey B, Di Nezza P, Diachkov I, Didenko S, Ding S, Dobishuk V, Docheva AD, Dolmatov A, Dong C, Donohoe AM, Dordei F, Dos Reis AC, Douglas L, Downes AG, Duan W, Duda P, Dudek MW, Dufour L, Duk V, Durante P, Duras MM, Durham JM, Dutta D, Dziurda A, Dzyuba A, Easo S, Eckstein E, Egede U, Egorychev A, Egorychev V, Eirea Orro C, Eisenhardt S, Ejopu E, Ek-In S, Eklund L, Elashri M, Ellbracht J, Ely S, Ene A, Epple E, Escher S, Eschle J, Esen S, Evans T, Fabiano F, Falcao LN, Fan Y, Fang B, Fantini L, Faria M, Farmer K, Fazzini D, Felkowski L, Feng M, Feo M, Fernandez Gomez M, Fernez AD, Ferrari F, Ferreira Rodrigues F, Ferreres Sole S, Ferrillo M, Ferro-Luzzi M, Filippov S, Fini RA, Fiorini M, Firlej M, Fischer KM, Fitzgerald DS, Fitzpatrick C, Fiutowski T, Fleuret F, Fontana M, Fontanelli F, Foreman LF, Forty R, Foulds-Holt D, Franco Sevilla M, Frank M, Franzoso E, Frau G, Frei C, Friday DA, Frontini L, Fu J, Fuehring Q, Fujii Y, Fulghesu T, Gabriel E, Galati G, Galati MD, Gallas Torreira A, Galli D, Gambetta S, Gandelman M, Gandini P, Gao H, Gao R, Gao Y, Gao Y, Gao Y, Garau M, Garcia Martin LM, Garcia Moreno P, García Pardiñas J, Garcia Plana B, Garg KG, Garrido L, Gaspar C, Geertsema RE, Gerken LL, Gersabeck E, Gersabeck M, Gershon T, Ghorbanimoghaddam Z, Giambastiani L, Giasemis FI, Gibson V, Giemza HK, Gilman AL, Giovannetti M, Gioventù A, Gironella Gironell P, Giugliano C, Giza MA, Gkougkousis EL, Glaser FC, Gligorov VV, Göbel C, Golobardes E, Golubkov D, Golutvin A, Gomes A, Gomez Fernandez S, Goncalves Abrantes F, Goncerz M, Gong G, Gooding JA, Gorelov IV, Gotti C, Grabowski JP, Granado Cardoso LA, Graugés E, Graverini E, Grazette L, Graziani G, Grecu AT, Greeven LM, Grieser NA, Grillo L, Gromov S, Gu C, Guarise M, Guittiere M, Guliaeva V, Günther PA, Guseinov AK, Gushchin E, Guz Y, Gys T, Hadavizadeh T, Hadjivasiliou C, Haefeli G, Haen C, Haimberger J, Hajheidari M, Halewood-Leagas T, Halvorsen MM, Hamilton PM, Hammerich J, Han Q, Han X, Hansmann-Menzemer S, Hao L, Harnew N, Harrison T, Hartmann M, Hasse C, He J, Heijhoff K, Hemmer F, Henderson C, Henderson RDL, Hennequin AM, Hennessy K, Henry L, Herd J, Heuel J, Hicheur A, Hill D, Hollitt SE, Horswill J, Hou R, Hou Y, Howarth N, Hu J, Hu J, Hu W, Hu X, Huang W, Hulsbergen W, Hunter RJ, Hushchyn M, Hutchcroft D, Idzik M, Ilin D, Ilten P, Inglessi A, Iniukhin A, Ishteev A, Ivshin K, Jacobsson R, Jage H, Jaimes Elles SJ, Jakobsen S, Jans E, Jashal BK, Jawahery A, Jevtic V, Jiang E, Jiang X, Jiang Y, Jiang YJ, John M, Johnson D, Jones CR, Jones TP, Joshi S, Jost B, Jurik N, Juszczak I, Kaminaris D, Kandybei S, Kang Y, Karacson M, Karpenkov D, Karpov M, Kauniskangas AM, Kautz JW, Keizer F, Keller DM, Kenzie M, Ketel T, Khanji B, Kharisova A, Kholodenko S, Khreich G, Kirn T, Kirsebom VS, Kitouni O, Klaver S, Kleijne N, Klimaszewski K, Kmiec MR, Koliiev S, Kolk L, Konoplyannikov A, Kopciewicz P, Koppenburg P, Korolev M, Kostiuk I, Kot O, Kotriakhova S, Kozachuk A, Kravchenko P, Kravchuk L, Kreps M, Kretzschmar S, Krokovny P, Krupa W, Krzemien W, Kubat J, Kubis S, Kucewicz W, Kucharczyk M, Kudryavtsev V, Kulikova E, Kupsc A, Kutsenko BK, Lacarrere D, Lafferty G, Lai A, Lampis A, Lancierini D, Landesa Gomez C, Lane JJ, Lane R, Langenbruch C, Langer J, Lantwin O, Latham T, Lazzari F, Lazzeroni C, Le Gac R, Lee SH, Lefèvre R, Leflat A, Legotin S, Lehuraux M, Leroy O, Lesiak T, Leverington B, Li A, Li H, Li K, Li L, Li P, Li PR, Li S, Li T, Li T, Li Y, Li Y, Li Z, Lian Z, Liang X, Lin C, Lin T, Lindner R, Lisovskyi V, Litvinov R, Liu G, Liu H, Liu K, Liu Q, Liu S, Liu Y, Liu Y, Liu YL, Lobo Salvia A, Loi A, Lomba Castro J, Long T, Lopes JH, Lopez Huertas A, López Soliño S, Lovell GH, Lucarelli C, Lucchesi D, Luchuk S, Lucio Martinez M, Lukashenko V, Luo Y, Lupato A, Luppi E, Lynch K, Lyu XR, Ma GM, Ma R, Maccolini S, Machefert F, Maciuc F, Mackay I, Madhan Mohan LR, Madurai MM, Maevskiy A, Magdalinski D, Maisuzenko D, Majewski MW, Malczewski JJ, Malde S, Malecki B, Malentacca L, Malinin A, Maltsev T, Manca G, Mancinelli G, Mancuso C, Manera Escalero R, Manuzzi D, Marangotto D, Marchand JF, Marchevski R, Marconi U, Mariani S, Marin Benito C, Marks J, Marshall AM, Marshall PJ, Martelli G, Martellotti G, Martinazzoli L, Martinelli M, Martinez Santos D, Martinez Vidal F, Massafferri A, Materok M, Matev R, Mathad A, Matiunin V, Matteuzzi C, Mattioli KR, Mauri A, Maurice E, Mauricio J, Mayencourt P, Mazurek M, McCann M, Mcconnell L, McGrath TH, McHugh NT, McNab A, McNulty R, Meadows B, Meier G, Melnychuk D, Merk M, Merli A, Meyer Garcia L, Miao D, Miao H, Mikhasenko M, Milanes DA, Minotti A, Minucci E, Miralles T, Mitchell SE, Mitreska B, Mitzel DS, Modak A, Mödden A, Mohammed RA, Moise RD, Mokhnenko S, Mombächer T, Monk M, Monroy IA, Monteil S, Morcillo Gomez A, Morello G, Morello MJ, Morgenthaler MP, Moron J, Morris AB, Morris AG, Mountain R, Mu H, Mu ZM, Muhammad E, Muheim F, Mulder M, Müller K, Mũnoz-Rojas F, Murta R, Naik P, Nakada T, Nandakumar R, Nanut T, Nasteva I, Needham M, Neri N, Neubert S, Neufeld N, Neustroev P, Newcombe R, Nicolini J, Nicotra D, Niel EM, Nikitin N, Nogga P, Nolte NS, Normand C, Novoa Fernandez J, Nowak G, Nunez C, Nur HN, Oblakowska-Mucha A, Obraztsov V, Oeser T, Okamura S, Oldeman R, Oliva F, Olocco M, Onderwater CJG, O'Neil RH, Otalora Goicochea JM, Ovsiannikova T, Owen P, Oyanguren A, Ozcelik O, Padeken KO, Pagare B, Pais PR, Pajero T, Palano A, Palutan M, Panshin G, Paolucci L, Papanestis A, Pappagallo M, Pappalardo LL, Pappenheimer C, Parkes C, Passalacqua B, Passaleva G, Passaro D, Pastore A, Patel M, Patoc J, Patrignani C, Pawley CJ, Pellegrino A, Pepe Altarelli M, Perazzini S, Pereima D, Pereiro Castro A, Perret P, Perro A, Petridis K, Petrolini A, Petrucci S, Pham H, Pica L, Piccini M, Pietrzyk B, Pietrzyk G, Pinci D, Pisani F, Pizzichemi M, Placinta V, Plo Casasus M, Polci F, Poli Lener M, Poluektov A, Polukhina N, Polyakov I, Polycarpo E, Ponce S, Popov D, Poslavskii S, Prasanth K, Promberger L, Prouve C, Pugatch V, Puill V, Punzi G, Qi HR, Qian W, Qin N, Qu S, Quagliani R, Rabadan Trejo RI, Rachwal B, Rademacker JH, Rama M, Ramírez García M, Ramos Pernas M, Rangel MS, Ratnikov F, Raven G, Rebollo De Miguel M, Redi F, Reich J, Reiss F, Ren Z, Resmi PK, Ribatti R, Ricart GR, Riccardi D, Ricciardi S, Richardson K, Richardson-Slipper M, Rinnert K, Robbe P, Robertson G, Rodrigues E, Rodriguez Fernandez E, Rodriguez Lopez JA, Rodriguez Rodriguez E, Rogovskiy A, Rolf DL, Rollings A, Roloff P, Romanovskiy V, Romero Lamas M, Romero Vidal A, Romolini G, Ronchetti F, Rotondo M, Roy SR, Rudolph MS, Ruf T, Ruiz Diaz M, Ruiz Fernandez RA, Ruiz Vidal J, Ryzhikov A, Ryzka J, Saborido Silva JJ, Sadek R, Sagidova N, Sahoo N, Saitta B, Salomoni M, Sanchez Gras C, Sanderswood I, Santacesaria R, Santamarina Rios C, Santimaria M, Santoro L, Santovetti E, Saputi A, Saranin D, Sarpis G, Sarpis M, Sarti A, Satriano C, Satta A, Saur M, Savrina D, Sazak H, Scantlebury Smead LG, Scarabotto A, Schael S, Scherl S, Schertz AM, Schiller M, Schindler H, Schmelling M, Schmidt B, Schmitt S, Schmitz H, Schneider O, Schopper A, Schulte N, Schulte S, Schune MH, Schwemmer R, Schwering G, Sciascia B, Sciuccati A, Sellam S, Semennikov A, Senghi Soares M, Sergi A, Serra N, Sestini L, Seuthe A, Shang Y, Shangase DM, Shapkin M, Shchemerov I, Shchutska L, Shears T, Shekhtman L, Shen Z, Sheng S, Shevchenko V, Shi B, Shields EB, Shimizu Y, Shmanin E, Shorkin R, Shupperd JD, Silva Coutinho R, Simi G, Simone S, Skidmore N, Skuza R, Skwarnicki T, Slater MW, Smallwood JC, Smith E, Smith K, Smith M, Snoch A, Soares Lavra L, Sokoloff MD, Soler FJP, Solomin A, Solovev A, Solovyev I, Song R, Song Y, Song Y, Song YS, Souza De Almeida FL, Souza De Paula B, Spadaro Norella E, Spedicato E, Speer JG, Spiridenkov E, Spradlin P, Sriskaran V, Stagni F, Stahl M, Stahl S, Stanislaus S, Stein EN, Steinkamp O, Stenyakin O, Stevens H, Strekalina D, Su Y, Suljik F, Sun J, Sun L, Sun Y, Swallow PN, Swientek K, Swystun F, Szabelski A, Szumlak T, Szymanski M, Tan Y, Taneja S, Tat MD, Terentev A, Terzuoli F, Teubert F, Thomas E, Thompson DJD, Tilquin H, Tisserand V, T'Jampens S, Tobin M, Tomassetti L, Tonani G, Tong X, Torres Machado D, Toscano L, Tou DY, Trippl C, Tuci G, Tuning N, Uecker LH, Ukleja A, Unverzagt DJ, Ursov E, Usachov A, Ustyuzhanin A, Uwer U, Vagnoni V, Valassi A, Valenti G, Valls Canudas N, Van Hecke H, van Herwijnen E, Van Hulse CB, Van Laak R, van Veghel M, Vazquez Gomez R, Vazquez Regueiro P, Vázquez Sierra C, Vecchi S, Velthuis JJ, Veltri M, Venkateswaran A, Vesterinen M, Vieira D, Vieites Diaz M, Vilasis-Cardona X, Vilella Figueras E, Villa A, Vincent P, Volle FC, Vom Bruch D, Vorobyev V, Voropaev N, Vos K, Vouters G, Vrahas C, Walsh J, Walton EJ, Wan G, Wang C, Wang G, Wang J, Wang J, Wang J, Wang J, Wang M, Wang NW, Wang R, Wang X, Wang XW, Wang Y, Wang Z, Wang Z, Wang Z, Ward JA, Watson NK, Websdale D, Wei Y, Westhenry BDC, White DJ, Whitehead M, Wiederhold AR, Wiedner D, Wilkinson G, Wilkinson MK, Williams M, Williams MRJ, Williams R, Wilson FF, Wislicki W, Witek M, Witola L, Wong CP, Wormser G, Wotton SA, Wu H, Wu J, Wu Y, Wyllie K, Xian S, Xiang Z, Xie Y, Xu A, Xu J, Xu L, Xu L, Xu M, Xu Z, Xu Z, Xu Z, Yang D, Yang S, Yang X, Yang Y, Yang Z, Yang Z, Yeroshenko V, Yeung H, Yin H, Yu CY, Yu J, Yuan X, Zaffaroni E, Zavertyaev M, Zdybal M, Zeng M, Zhang C, Zhang D, Zhang J, Zhang L, Zhang S, Zhang S, Zhang Y, Zhang Y, Zhang YZ, Zhao Y, Zharkova A, Zhelezov A, Zheng XZ, Zheng Y, Zhou T, Zhou X, Zhou Y, Zhovkovska V, Zhu LZ, Zhu X, Zhu X, Zhu Z, Zhukov V, Zhuo J, Zou Q, Zuliani D, Zunica G. Enhanced Production of Λ_{b}^{0} Baryons in High-Multiplicity pp Collisions at sqrt[s]=13 TeV. PHYSICAL REVIEW LETTERS 2024; 132:081901. [PMID: 38457697 DOI: 10.1103/physrevlett.132.081901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 12/19/2023] [Accepted: 01/09/2024] [Indexed: 03/10/2024]
Abstract
The production rate of Λ_{b}^{0} baryons relative to B^{0} mesons in pp collisions at a center-of-mass energy sqrt[s]=13 TeV is measured by the LHCb experiment. The ratio of Λ_{b}^{0} to B^{0} production cross sections shows a significant dependence on both the transverse momentum and the measured charged-particle multiplicity. At low multiplicity, the ratio measured at LHCb is consistent with the value measured in e^{+}e^{-} collisions, and increases by a factor of ∼2 with increasing multiplicity. At relatively low transverse momentum, the ratio of Λ_{b}^{0} to B^{0} cross sections is higher than what is measured in e^{+}e^{-} collisions, but converges with the e^{+}e^{-} ratio as the momentum increases. These results imply that the evolution of heavy b quarks into final-state hadrons is influenced by the density of the hadronic environment produced in the collision. Comparisons with several models and implications for the mechanisms enforcing quark confinement are discussed.
Collapse
|
12
|
Deng J, Zhang W, Xu M, Liu X, Ren T, Li S, Sun Q, Xue C, Zhou J. Value of spectral CT parameters in predicting the efficacy of neoadjuvant chemotherapy for gastric cancer. Clin Radiol 2024; 79:51-59. [PMID: 37914603 DOI: 10.1016/j.crad.2023.08.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Revised: 07/26/2023] [Accepted: 08/30/2023] [Indexed: 11/03/2023]
Abstract
AIM To investigate the value of pre-chemotherapy spectral computed tomography (CT) parameters in predicting neoadjuvant chemotherapy (NAC) response in gastric cancer (GC). MATERIALS AND METHODS Sixty patients with GC who received NAC and underwent spectral CT examination before chemotherapy were enrolled retrospectively and divided into a responsive group and a non-responsive group according to the postoperative pathological tumour regression grade. Clinical characteristics were collected. The iodine concentration (IC), water concentration (WC), and effective atomic number (Eff-Z) of the portal venous phases were measured before chemotherapy, and IC was normalised to that of the aorta to provide the normalised IC (NIC). An independent samples t-test, Mann-Whitney U-test, or chi-square test was used to analyse the differences between the two groups, and the receiver operating curve (ROC) was used to evaluate the predictive performance of different variables. RESULTS The neutrophil-to-lymphocyte ratio (NLR) was lower in the responsive group than in the non-responsive group (p<0.05). IC, NIC, and Eff-Z values were significantly higher in the responsive group than in the non-responsive group (p<0.01). The areas under the ROC curves for the NLR, IC, NIC, and Eff-Z were 0.694, 0.688, 0.799, and 0.690, respectively. The combination of NIC, Eff-Z, and NLR values showed good diagnostic performance in predicting response to NAC in GC, with an area under the ROC curve of 0.857, 76.92% sensitivity, 80% accuracy, and 85.71% specificity. CONCLUSION Spectral CT parameters may serve as non-invasive tools for predicting the response to NAC in patients with GC.
Collapse
|
13
|
Ma YP, Deng J, Fu ZR, Chen CH, Wang XH, Wang X, Weng JW, Shen YH. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age]. ZHONGHUA ER KE ZA ZHI = CHINESE JOURNAL OF PEDIATRICS 2023; 61:983-988. [PMID: 37899337 DOI: 10.3760/cma.j.cn112140-20230731-00057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/31/2023]
Abstract
Objective: To analyze the efficacy and safety of the sodium channel blockers (SCB) antiseizure medication in the treatment of focal epilepsy in infants under 6 months of age. Methods: This was a case series study. Infants with focal epilepsy with onset within 6 months of age and treated with SCB attending the Department of Neurology of Beijing Children's Hospital from June 2016 to April 2022 were collected. The clinical data, auxiliary examinations, SCB application, efficacy, adverse reactions, and prognosis were analyzed retrospectively. Patients were grouped according to type of seizure and epileptic syndrome, age of onset and etiology. Chi square test and Fisher exact test were used to analyze the differences between groups statistically. Results: A total of 118 infants were enrolled, 65 males and 53 females, with an age of epilepsy onset of 56 (4, 114) days. Developmental and epileptic encephalopathy was diagnosed in 60 infants, 39 had self-limited neonatal and (or) infantile epilepsy, and 19 had non-syndromic focal epilepsy. Application of SCB: 106 used oxcarbazepine, 2 used lacosamide, 9 switched from oxcarbazepine to lacosamide or a combination of 2 SCB, and 1 used oxcarbazepine, lacosamide, and lamotrigine successively; oxcarbazepine was the first choice in 46 cases. The age at which SCB was applied was 103 (53, 144) days. The children were followed up for 6 months to 6 years. SCB was effective in 89 cases (75.4%), including 70 cases (59.3%) who achieved seizure freedom. The seizure-free rate was higher in the focal epilepsy only group than in the group with other seizure types (64.4% (65/101) vs. 4/17, χ²=9.99, P<0.05). The responder and seizure-free rates were all higher in the group with the onset age of >3-6 months than the group >1-3 months (84.4% (38/45) vs. 62.5% (20/32), 73.3% (33/45) vs. 46.9% (15/32), χ²=4.85 and 5.58, both P<0.05). With the exception of variants in the PRRT2 gene, those with variants in sodium or potassium channels had higher responder and seizure-free rates than those with variants in other genes(86.2% (25/29) vs. 45.5% (10/22), 62.1% (18/29) vs. 22.7% (5/22), χ²=9.65 and 7.82,both P<0.05). The most common adverse event was transient hyponatremia, which happened in 66 cases (55.9%). There were 9 cases of rash, which subsided in 6 cases after discontinuing oxcarbazepine and switching to lacosamide, and 7 cases of electrocardiogram abnormalities, which improved after withdrawing oxcarbazepine and changing to lacosamide in 1 case. Conclusion: SCB are effective and tolerable in the treatment of focal epilepsy in infants under 6 months of age, with better efficacy in patients with genetic variants of the sodium or potassium channel, focal seizures only, and seizure onset >3-6 months of age.
Collapse
|
14
|
Peterson NV, Kendal J, Savjani RR, Wessel L, Deng J, Crompton J, Bernthal NM, Eilber FC, Reddy VK, Kalbasi A. Surgical Outcomes in Patients Treated with 5-Day Preoperative Radiotherapy for Soft Tissue Sarcoma. Int J Radiat Oncol Biol Phys 2023; 117:e333. [PMID: 37785173 DOI: 10.1016/j.ijrobp.2023.06.2386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Treatment for high-risk soft tissue sarcoma (STS) of the extremity/trunk includes radiation therapy (RT) and surgical resection. Initial results of a phase 2 single arm trial of 5-day preoperative RT demonstrated acceptable safety and local control. Here we report an update of detailed surgical outcomes among patients treated with 5-day preoperative RT alone on the original phase 2 study, as well as an ongoing expansion cohort. MATERIALS/METHODS We conducted an updated analysis of surgical complications from a previously reported phase 2 trial of 50 patients with high-risk extremity/trunk STS treated with 5-day preoperative RT (30 Gy over 5 consecutive daily fractions) and surgery. The current analysis includes additional patients from an ongoing IRB-approved expansion cohort of the phase 2 study, which was designed to compare wound complication rates between patients receiving neoadjuvant chemotherapy and those receiving RT alone. However, given that the primary endpoint of this study has not matured, here we present only the data for patients treated with 5-day preoperative RT alone (n = 44; data cutoff date: February 17, 2022). We generated a secure prospective patient database and extracted data including demographic variables, cancer characteristics and surgical outcomes. Minimum post-operative follow-up was 90 days. Statistical analysis was performed using R (v4.2). RESULTS From a total of 94 patients, mean age was 57 (17-90), 40 (42.5%) were female, 10 (10.6%) were diabetic and 8 patients (8.5%) were active smokers or had a >10 pack-year smoking history. Median follow up was 24 months (IQR 10.6-41.8). The most common histologic diagnosis was undifferentiated pleomorphic sarcoma (n = 38, 40.4%). The most common location was the lower extremity (n = 57, 60.6%). Overall, 26 (27.7%) patients experienced surgical wound complications. In the lower extremity, wound complications occurred in 18 patients (31.6%). In all other sites, wound complications occurred in 8 patients (21.6%) (p = 0.41). Twenty-seven (28.7%) cases required local tissue advancement for primary closure and 12 of these patients (44.4%) experienced a wound complication (p = 0.04). Wound dehiscence occurred in 18 patients at a median duration of 43.5 days (IQR 40.3-85.3) from surgery, comprising 69.2% of all wound complications. Secondary surgical intervention was required in 28 patients (29.8%), of which 7 were oncologic re-excisions and 15 were irrigation and debridement. On multivariate analysis, the use of advancement flaps (OR = 5.39; p = 0.004) and diabetes (OR = 4.08; p = 0.07) were associated with wound complications. CONCLUSION Five-day preoperative RT for STS results in rates of wound complications comparable to standard fractionation. We identified local advancement flaps as the primary factor associated with wound complications. STS of the lower extremity that require complex closure warrant close attention for dehiscence.
Collapse
|
15
|
We C, Deng J, Xing J, Wang Z, Song Z, Wang D, Jiang J, Wang X, Zhou A, Zou W, Li J. A hybrid polymer protective layer with uniform Li + flux and self-adaption enabling dendrite-free Li metal anodes. NANOSCALE ADVANCES 2023; 5:5094-5101. [PMID: 37705800 PMCID: PMC10496765 DOI: 10.1039/d3na00248a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Accepted: 07/08/2023] [Indexed: 09/15/2023]
Abstract
Lithium (Li) metal is considered as an ideal negative electrode material for next-generation secondary batteries; however, the hideous dendrite growth and parasitic reactions hinder the practical applications of Li metal batteries. Herein, a hybrid polymer film composed of polyvinyl alcohol (PVA) and polyacrylic acid (PAA) is adopted as an artificial protective layer to inhibit the dendritic formation and side reactions in Li metal anodes. PVA with large quantities of polar functional groups can induce even distribution of Li ions (Li+). Alternatively, PAA can in situ react with Li metal to form highly elastic and ionic conducting lithium polyacrylic acid (LiPAA), thereby enabling tight contact and flexible self-adaption with Li metal anodes. Therefore, such a rationally designed functional composite layer, with good binding ability and relatively high Li+ conductivity, as well as excellent capability of homogenizing Li+ flow, accordingly enables Li metal anodes to reveal dendrite-free plating/stripping behaviours and minimum volume variation. As a result, the PVA-PAA modified Li metal anode delivered stable cycling for 700 and 250 h, respectively, at current densities of 1 and 3 mA cm-2 under an areal capacity of 1 mA h cm-2, in a carbonate ester-based electrolyte without any additive, exhibiting boosted cycling and rate performances. The Li anode with a functional PVA-PAA hybrid interlayer can maintain the dense and smooth texture without dendrite formation after long cycles. The full cell of Li|LiFeO4 with our modified Li anode and a cathode with a high areal capacity of 2.45 mA h cm-2 delivers, change to achieved a long-term lifespan of 180 cycles at 1.0 C, with a capacity retention of 96.7%. This work demonstrates a simple and effective strategy of designing multi-functional artificial protective layers, targeting dendrite-free Li anodes.
Collapse
|
16
|
Deng J, Jin C, Zhu L, Liu L, Huang Y, Zhao P, Gao S. Effects of Different Primers on the Bond Strength to Properly and Excessively Etched Ceramic-coated Zirconia. Oper Dent 2023; 48:552-563. [PMID: 37482890 DOI: 10.2341/22-122-l] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/18/2023] [Indexed: 07/25/2023]
Abstract
PURPOSE To determine the effects of various primers on the immediate and long-term bond strength of ceramic-coated ultratranslucent zirconia that is properly or excessively etched. METHODS AND MATERIALS Ceramic-coated zirconia plates were etched with 9.5% hydrofluoric acid (HF) for 2 or 5 minutes, after which the surface morphology and elemental composition were examined. The etched specimens were treated with different primers including methacryloyloxydecyl dihydrogen phosphate (MDP)-only containing primer, silane-only containing primer, MDP and silane-containing ceramic primer as well as MDP and silane-containing adhesive system. For surface contact angle and shear bond strength (SBS) data, the difference between groups was evaluated by one-way analysis of variance (ANOVA) and three-way ANOVA factorial analysis, respectively. The statistical significance level of 0.05 was set and the Tukey test and the Dunnett-T3 test were used for post-hoc multiple comparisons. RESULTS Excessive etching (9.5% HF for 5 minutes) led to overconsumption of the glass layer and exposure of zirconia substrate compared to proper etching (9.5% HF for 2 minutes). Among different primers, the surface contact angle of the silane-only containing primer group was the lowest. The silane-only containing primer and MDP and silane-containing ceramic primer produced higher shear bond strength of properly and excessively etched ceramic-coated zirconia, respectively, both before and after thermal aging. CONCLUSIONS The silane-only containing primer and MDP and silane-containing primer can obtain better immediate and long-term shear bond strength for properly and excessively etched ceramic-coated zirconia, respectively.
Collapse
|
17
|
Deng J, Li MT, Yang MC, Wen ZM, Li XK, Zhu CY, Wang T, Yan T, Tang M, Pu Y, Zuo HY. Different sedation profiles with ciprofol compared to propofol represented by objective sedation level assessments by BIS and its acute hemodynamic impact in 3 escalated doses of ciprofol and propofol in healthy subjects: a single-center, open-label, randomized, 2-stage, 2-way crossover trial. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2023; 27:7914-7923. [PMID: 37750620 DOI: 10.26355/eurrev_202309_33550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 09/27/2023]
Abstract
OBJECTIVE To compare the sedation profiles and the pharmacokinetic, pharmacodynamic and safety characteristics of ciprofol and propofol at 3 escalated dose levels in healthy Chinese male subjects. PATIENTS AND METHODS Eighteen subjects were planned to be enrolled into 3 dose groups in turn: group 1 (ciprofol-0.4 mg/kg vs. propofol-2.0 mg/kg), group 2 (ciprofol-0.6 mg/kg vs. propofol-3.0 mg/kg) and group 3 (ciprofol-0.8 mg/kg vs. propofol-4.0 mg/kg). They were randomly assigned into a ciprofol or propofol group in a ratio of 1:1, with sequences of ciprofol-propofol or propofol-ciprofol, separated with a washout period of at least 48 h. RESULTS A total of 19 subjects were enrolled and 18 completed the trial. The median time to being fully alert after induction by ciprofol was longer than for propofol. The bispectral index (BIS) recovered significantly slower with ciprofol than with propofol 5 min and 10 min after reaching its lowest points. Systolic blood pressure (group 1: p=0.041; group 2: p=0.015; group 3: p=0.004) and mean arterial pressures (group 1: p=0.026; group 2: p=0.015; group 3: p=0.004) measured by the area under the curve below the baseline during the 2 min after induction were significantly less for ciprofol compared to propofol, but a significant change in diastolic blood pressure was only observed in group 3 (p=0.002). Eighteen (100.0%) subjects experienced 47 ciprofol-related treatment emergent adverse events (TEAEs) and 17 (94.4%) subjects had 54 propofol-related TEAEs, which were mainly hypotension, involuntary movements, respiratory depression, and pain at the injection site with severity of grade 1 or 2. CONCLUSIONS Ciprofol may be well tolerated at higher doses in the clinical practice and exhibited significantly different sedation profiles to propofol.
Collapse
|
18
|
Li Y, Meng J, Duan P, Wu R, Shi Y, Zhang L, Yan C, Deng J, Zhang X. Transport Layer Engineering by Hydrochloric Acid for Efficient Perovskite Solar Cells with a High Open-Circuit Voltage. ACS APPLIED MATERIALS & INTERFACES 2023; 15:23208-23216. [PMID: 37133487 DOI: 10.1021/acsami.3c02376] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
A large number of defect states that exist at the interface between a perovskite film and an electron transport layer (ETL) are detrimental to the efficiency and the stability of perovskite solar cells (PSCs). It is still a challenge to simultaneously passivate the defects on both sides by a stable and low-cost ion compound. Herein, we demonstrate a simple and effective versatile strategy by introducing hydrochloric acid into SnO2 precursor solution to passivate the defects in both SnO2 and perovskite layers and simultaneously reduce the interface energy barrier, ultimately achieving a high-performance and hysteresis-free PSCs. Hydrogen ions can neutralize -OH groups on the SnO2 surface, whereas the Cl- can not only combine with Sn4+ in ETL but also suppress the Pb-I antisite defects formed at the buried interface. The reduced nonradiative recombination and the favorable energy level alignment result in a significantly increased efficiency from 20.71 to 22.06% of PSCs due to the enhancement of open-circuit voltage. In addition, the stability of the device can also be improved. This work presents a facile and promising approach for the development of highly efficient PSCs.
Collapse
|
19
|
Zhou L, Fang F, Deng J, Liu SJ, Chen CH, Li H, Ren CH, Wu Y. [Clinical features of 6 children with uridine-responsive developmental epileptic encephalopathy 50 caused by CAD gene variants]. ZHONGHUA ER KE ZA ZHI = CHINESE JOURNAL OF PEDIATRICS 2023; 61:453-458. [PMID: 37096266 DOI: 10.3760/cma.j.cn112140-20221108-00950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
Abstract
Objective: To analyze the clinical features of children with uridine responsive developmental epileptic encephalopathy 50 (DEE50) caused by CAD gene variants. Methods: A retrospective study was conducted on 6 patients diagnosed with uridine-responsive DEE50 caused by CAD gene variants at Beijing Children's Hospital and Peking University First Hospital from 2018 to 2022. The epileptic seizures, anemia, peripheral blood smear, cranial magnetic resonance imaging (MRI), visual evoked potential (VEP), genotype features and the therapeutic effect of uridine were descriptively analyzed. Results: A total of 6 patients, including 3 boys and 3 girls, aged 3.5(3.2,5.8) years, were enrolled in this study. All patients presented with refractory epilepsy, anemia with anisopoikilocytosis and global developmental delay with regression. The age of epilepsy onset was 8.5 (7.5, 11.0) months, and focal seizures were the most common seizure type (6 cases). Anemia ranged from mild to severe. Four patients had peripheral blood smears prior to uridine administration, showing erythrocytes of variable size and abnormal morphology, and normalized at 6 (2, 8) months after uridine supplementation. Two patients suffered from strabismus, 3 patients had VEP examinations, indicating of suspicious optic nerve involvement, and normal fundus examinations. VEP was re-examined at 1 and 3 months after uridine supplementation, suggesting significant improvement or normalization. Cranial MRI were performed at 5 patients, demonstrating cerebral and cerebellar atrophy. They had cranial MRI re-examined after uridine treatment with a duration of 1.1 (1.0, 1.8) years, indicating significant improvement in brain atrophy. All patients received uridine orally at a dose of 100 mg/(kg·d), the age at initiation of uridine treatment was 1.0 (0.8, 2.5) years, and the duration of treatment was 2.4 (2.2, 3.0) years. Immediate cession of seizures was observed within days to a week after uridine supplementation. Four patients received uridine monotherapy and were seizure free for 7 months, 2.4 years, 2.4 years and 3.0 years respectively. One patient achieved seizure free for 3.0 years after uridine supplementation and had discontinued uridine for 1.5 years. Two patients were supplemented with uridine combined with 1 to 2 anti-seizure medications and had a reduced seizure frequency of 1 to 3 times per year, and they had achieved seizure free for 8 months and 1.4 years respectively. Conclusions: The clinical manifestations of DEE50 caused by CAD gene variants present a triad of refractory epilepsy, anemia with anisopoikilocytosis, and psychomotor retardation with regression, accompanied by suspected optic nerve involvement, all of which respond to uridine treatment. Prompt diagnosis and immediate uridine supplementation could lead to significant clinical improvement.
Collapse
|
20
|
Liu Q, Dai Y, Yu H, Shen Y, Deng J, Lu W, Jin J. [NKD1 promotes glucose uptake in colon cancer cells by activating YWHAE transcription]. NAN FANG YI KE DA XUE XUE BAO = JOURNAL OF SOUTHERN MEDICAL UNIVERSITY 2023; 43:585-589. [PMID: 37202194 DOI: 10.12122/j.issn.1673-4254.2023.04.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
OBJECTIVE Bo investigate the regulatory relationship between NKD1 and YWHAE and the mechanism of NKD1 for promoting tumor cell proliferation. METHODS HCT116 cells transfected with pcDNA3.0-NKD1 plasmid, SW620 cells transfected with NKD1 siRNA, HCT116 cells with stable NKD1 overexpression (HCT116-NKD1 cells), SW620 cells with nkd1knockout (SW620-nkd1-/- cells), and SW620-nkd1-/- cells transfected with pcDNA3.0-YWHAE plasmid were examined for changes in mRNA and protein expression levels of YWHAE using qRT-PCR and Western blotting. Chromatin immunoprecipitation (ChIP) assay was used to detect the binding of NKD1 to the promoter region of YWHAE gene. The regulatory effect of NKD1 on YWHAE gene promoter activity was analyzed by dual-luciferase reporter gene assay, and the interaction between NKD1 and YWHAE was analyzed with immunofluorescence assay. The regulatory effect of NKD1 on glucose uptake was examined in the tumor cells. RESULTS In HCT116 cells, overexpression of NKD1 significantly enhanced the expression of YWHAE at both the mRNA and protein levels, while NKD1 knockout decreased its expression in SW620 cells (P < 0.001). ChIP assay showed that NKD1 protein was capable of binding to the YWHAE promoter sequence; dual luciferase reporter gene assay showed that NKD1 overexpression (or knockdown) in the colon cancer cells significantly enhanced (or reduced) the transcriptional activity of YWHAE promoter (P < 0.05). Immunofluorescence assay demonstrated the binding of NKD1 and YWHAE proteins in colon cancer cells. NKD1 knockout significantly reduced glucose uptake in colon cancer cells (P < 0.01), while YWHAE overexpression restored the glucose uptake in NKD1-knockout cells (P < 0.05). CONCLUSION NKD1 protein activates the transcriptional activity of YWHAE gene to promote glucose uptake in colon cancer cells.
Collapse
|
21
|
Wang X, Cui S, Yang M, Zhao L, Tan B, Liu T, Wang G, Deng J, Luo J. Tuning crystal orientation and chiral spin order in Mn3Ge by annealing process and ion implantation. NANOTECHNOLOGY 2023; 34. [PMID: 37075714 DOI: 10.1088/1361-6528/acce40] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Accepted: 04/18/2023] [Indexed: 05/03/2023]
Abstract
The non-collinear antiferromagnetic Weyl semimetal Mn3X (X=Ga, Ge, Sn) system has attracted a lot of attentions owing to its robust anomalous Hall effect (AHE), large spin Hall angle and small net magnetization at room temperature. The high spin-charge interconversion efficiency makes it a super candidate in topological antiferromagnetic spintronic devices, which could facilitate ultra-fast operation of high-density devices with low energy consumption. In this work, we have realized to obtain different chiral spin structures in Heusler alloy Mn3Ge thin films, which originate from different crystalline orientations. The high-quality (0002)- and (200)-oriented single phase hexagonal Mn3Ge films are achieved by controllable growth, annealing process and ion implantation. The various magnetic properties and AHE behaviors are observed along a and c crystal axes, equivalent to magnetic field in and out of the inverse triangular spin plane. The observation demonstrates the manipulation of crystal structure accompanied with chiral spin order in a non-collinear antiferromagnetic Mn3Ge film, which is induced by energy conversion and defect introduction. The in-situ thermal treatment induces crystal phase rotation up to 90° and robust AHE modulation, which is significantly important and highly desirable for flexible spin memory device applications.
.
Collapse
|
22
|
Deng J, Wang Z, Xu Z, Lai Y, Zheng R, Gao W, Shi J, Sun Y. Blood eosinophils to direct oral corticosteroid treatment for patients with nasal polyps - an open label, non-inferiority, randomized control trial. Rhinology 2023:3073. [PMID: 37066680 DOI: 10.4193/rhin22.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/18/2023]
Abstract
BACKGROUND Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous disorder. We aimed to evaluate the value of blood eosinophil count (BEC) for guiding oral corticosteroid therapy for CRSwNP. METHODS Subjects with CRSwNP were entered into a 2:1 randomized biomarker-directed corticosteroid versus standard therapy study base on the principle of potential benefits to patients. Subjects in the standard arm received oral prednisone (30mg/day) alone for 7 days, whereas in the biomarker-directed arm, prednisone (30mg/day), or nasal steroid spray (budesonide 256ug/day) was given according to the BEC which was measured to define eosinophil-high and -low CRSwNP (BEC ≥ and < 0.37×109/L, respectively). The primary outcome was the total nasal symptom scores (TNSS) of the two arms with the non-inferiority margin of 1.8. Secondary outcomes included nasal polyp size scores (NPSS) and SNOT-22. Patients were followed up the day after last dose of treatment. RESULTS A total of 105 subjects with CRSwNP were randomized into the biomarker-directed therapy group or the standard care group. The biomarker therapy demonstrated non-inferiority compared to standard care. There were no between-group differences for TNSS, NPSS and SNOT-22 improvements after treatment. Comparisons of TNSS, SNOT-22 and NPSS revealed no significant difference in terms of the effectiveness ratios of the biomarker-directed therapy and the standard care. CONCLUSION A biomarker-directed strategy using the BEC can be used to direct corticosteroid therapy without increasing treatment failure or worsening of symptoms in patients with CRSwNP.
Collapse
|
23
|
Miao K, Cao WH, Lyu J, Yu CQ, Wang SF, Huang T, Sun DJY, Liao CX, Pang YJ, Pang ZC, Yu M, Wang H, Wu XP, Dong Z, Wu F, Jiang GH, Wang XJ, Liu Y, Deng J, Lu L, Gao WJ, Li LM. [A descriptive analysis of hyperlipidemia in adult twins in China]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2023; 44:544-551. [PMID: 37147824 DOI: 10.3760/cma.j.cn112338-20221007-00859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
Objective: To describe the distribution characteristics of hyperlipidemia in adult twins in the Chinese National Twin Registry (CNTR) and explore the effect of genetic and environmental factors on hyperlipidemia. Methods: Twins recruited from the CNTR in 11 project areas across China were included in the study. A total of 69 130 (34 565 pairs) of adult twins with complete information on hyperlipidemia were selected for analysis. The random effect model was used to characterize the population and regional distribution of hyperlipidemia among twins. The concordance rates of hyperlipidemia were calculated in monozygotic twins (MZ) and dizygotic twins (DZ), respectively, to estimate the heritability. Results: The age of all participants was (34.2±12.4) years. This study's prevalence of hyperlipidemia was 1.3% (895/69 130). Twin pairs who were men, older, living in urban areas, married,had junior college degree or above, overweight, obese, insufficient physical activity, current smokers, ex-smokers, current drinkers, and ex-drinkers had a higher prevalence of hyperlipidemia (P<0.05). In within-pair analysis, the concordance rate of hyperlipidemia was 29.1% (118/405) in MZ and 18.1% (57/315) in DZ, and the difference was statistically significant (P<0.05). Stratified by gender, age, and region, the concordance rate of hyperlipidemia in MZ was still higher than that in DZ. Further, in within-same-sex twin pair analyses, the heritability of hyperlipidemia was 13.04% (95%CI: 2.61%-23.47%) in the northern group and 18.59% (95%CI: 4.43%-32.74%) in the female group, respectively. Conclusions: Adult twins were included in this study and were found to have a lower prevalence of hyperlipidemia than in the general population study, with population and regional differences. Genetic factors influence hyperlipidemia, but the genetic effect may vary with gender and area.
Collapse
|
24
|
Wang YT, Cao WH, Lyu J, Yu CQ, Wang SF, Huang T, Sun DJY, Liao CX, Pang YJ, Pang ZC, Yu M, Wang H, Wu XP, Dong Z, Wu F, Jiang GH, Wang XJ, Liu Y, Deng J, Lu L, Gao WJ, Li LM. [A descriptive analysis on hypertension in adult twins in China]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2023; 44:536-543. [PMID: 37147823 DOI: 10.3760/cma.j.cn112338-20221007-00860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
Objective: To describe the distribution characteristics of hypertension among adult twins in the Chinese National Twin Registry (CNTR) and to provide clues for exploring the role of genetic and environmental factors on hypertension. Methods: A total of 69 220 (34 610 pairs) of twins aged 18 and above with hypertension information were selected from CNTR registered from 2010 to 2018. Random effect models were used to describe the population and regional distribution of hypertension in twins. To estimate the heritability, the concordance rates of hypertension were calculated and compared between monozygotic twins (MZ) and dizygotic twins (DZ). Results: The age of all participants was (34.1±12.4) years. The overall self-reported prevalence of hypertension was 3.8%(2 610/69 220). Twin pairs who were older, living in urban areas, married, overweight or obese, current smokers or ex-smokers, and current drinkers or abstainers had a higher self-reported prevalence of hypertension (P<0.05). Analysis within the same-sex twin pairs found that the concordance rate of hypertension was 43.2% in MZ and 27.0% in DZ, and the difference was statistically significant (P<0.001). The heritability of hypertension was 22.1% (95%CI: 16.3%- 28.0%). Stratified by gender, age, and region, the concordance rate of hypertension in MZ was still higher than that in DZ. The heritability of hypertension was higher in female participants. Conclusions: There were differences in the distribution of hypertension among twins with different demographic and regional characteristics. It is indicated that genetic factors play a crucial role in hypertension in different genders, ages, and regions, while the magnitude of genetic effects may vary.
Collapse
|
25
|
Zhou H, Wang SW, Shi JC, Deng J, Shi QS, Lai JM, Xiao GZ, Tong ZY. [Effect of diurnal temperature range on the number of elderly inpatients with ischemic stroke in Hunan Province]. ZHONGHUA YU FANG YI XUE ZA ZHI [CHINESE JOURNAL OF PREVENTIVE MEDICINE] 2023; 57:528-534. [PMID: 37032163 DOI: 10.3760/cma.j.cn112150-20220620-00629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/11/2023]
Abstract
Objective: To study the effect of diurnal temperature range on the number of elderly inpatients with ischemic stroke in Hunan Province. Method: Demographic and disease data, meteorological data, air quality data, population, economic and health resource data of elderly inpatients with ischemic stroke were collected in 122 districts/counties of Hunan Province from January to December 2019. The relationships between the diurnal temperature range and the number of elderly inpatients with ischemic stroke were analyzed by using the distributed lag non-linear model, including the cumulative lag effect of the diurnal temperature range in different seasons, extremely high diurnal temperature range and extremely low diurnal temperature range. Results: In 2019, 152 875 person-times were admitted to the hospital for ischemic stroke in the elderly in Hunan Province. There was a non-linear relationship between the diurnal temperature range and the number of elderly patients with ischemic stroke, with different lag periods. In spring and winter, with the decrease in diurnal temperature range, the risk of admission of elderly patients with ischemic stroke increased (Ptrend<0.001, Ptrend=0.002);in summer, with the increase in diurnal temperature range, the risk of admission of elderly patients with ischemic stroke increased (Ptrend=0.024);in autumn, the change in the diurnal temperature range would not cause a change in admission risk (Ptrend=0.089). Except that the lag effect of the extremely low diurnal temperature range in autumn was not obvious, the lag effect occurred in other seasons under extremely low and extremely high diurnal temperature ranges. Conclusion: The high diurnal temperature range in summer and the low diurnal temperature range in spring and winter will increase the risk of admission of elderly patients with ischemic stroke, and the risk of admission of elderly patients with ischemic stroke will lag under the extremely low and extremely high diurnal temperature ranges in the above three seasons.
Collapse
|